10-Q

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2015

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to ________

Commission File Number: 333-175044

Alkame Holdings, Inc.
(Exact name of registrant as specified in its charter)

Nevada	98-0661455
(State or other jurisdiction of incorporation organization)	(I.R.S. Employer Identification No.)

3651 Lindell Road, Suite D #356, Las Vegas, NV 89103
(Address of principal executive offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: 702-273-9714

_______________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[ ]		Accelerated filer	[ ]
Non-accelerated filer	[ ]	(Do not check if a smaller reporting company)	Smaller reporting company	[X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 198,485,547 as February 9, 2016.

ALKAME HOLDINGS, INC.

INDEX
			Page
PART I.	FINANCIAL INFORMATION
	ITEM 1	Financial Statements	3
		Condensed consolidated balance sheets as of September 30, 2015 (unaudited) and December 31, 2014	F-1
		Condensed consolidated statements of operations for the three and nine months ended September 30, 2015 and 2014 (unaudited)	F-2
		Condensed consolidated statements of cash flows for the nine months ended September 30, 2015 and 2014 (unaudited)	F-3
		Notes to condensed consolidated financial statements (unaudited)	F-4
	ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
	ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	9
	ITEM 4.	Controls and Procedures	9
PART II.	OTHER INFORMATION
	ITEM 1.	Legal Proceedings	10
	ITEM 1A.	Risk Factors	10
	ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	10
	ITEM 3.	Defaults Upon Senior Securities	12
	ITEM 4.	Mine Safety Disclosures	12
	ITEM 5.	Other Information	12
	ITEM 6.	Exhibits	12
	SIGNATURES		13

2

PART 1 - FINANCIAL INFORMATION

Item 1. Financial Statements.

Forward Looking Statements

This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, any of which may cause our company’s or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These risks include, by way of example and not in limitation:

• the uncertainty that we will not be able to successfully execute our business plan;
• risks related to the large number of established and well-financed entities that are actively seeking suitable business opportunities;
• risks related to the failure to successfully manage or achieve growth of a new business opportunity; and
• other risks and uncertainties related to our business strategy.

This list is not an exhaustive list of the factors that may affect any of our forward-looking statements. These and other factors should be considered carefully and readers should not place undue reliance on our forward-looking statements.

Forward looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and we undertake no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Our unaudited condensed consolidated financial statements are stated in United States dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended September 30, 2015, are not necessarily indicative of the results that can be expected for the full year.

In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common stock” refer to the common shares in our capital stock.

As used in this quarterly report, the terms “we”, “us”, “our”, “our company” and “Alkame” mean Alkame Holdings, Inc., unless otherwise stated.

3

ALKAME HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
		September 30,			December 31,
		2015			2014
		(Unaudited)
ASSETS
Current assets:
Cash	$	749		$	172,730
Accounts receivable (net of reserve for bad debts of $148,000 and $23,000, respectively)		106,558			82,510
Accounts receivable other		1,008			—
Prepaid expenses - current		7,000			260,000
Inventory		172,857			70,243
Total current assets		288,172			585,483
Fixed and intangible assets:
Manufacturing equipment, net		129,161			11,149
Software		13,496			17,995
Intangible assets, net		1,080,051			4,509
Total fixed and intangible assets, net		1,222,709			33,653
Other assets:
Deferred finance costs		11,898			63,375
Investments		25,630			68,400
Total other assets		37,528			131,775
Total assets	$	1,548,409		$	750,911
LIABILITIES AND STOCKHOLDERS DEFICIT
Current liabilities:
Accounts payable and accrued expenses	$	698,961		$	544,530
Accrued interest		237,852			146,046
Accrued compensation		510,000			—
Loans from officer		26,456			3,489
Notes payable		990,005			762,000
Note due Xtreme Shareholders		207,000			—
Convertible debentures (net of debt discount of $64,455 and $280,288, respectively)		471,546			168,961
Derivative instrument liability		873,348			1,018,782
Series C Convertible Preferred Stock to be issued		1,425,000			—
Total current liabilities		5,440,167			2,643,808
Long-term liabilities:
Notes payable - long term		26,199			131,490
Convertible debt - long term (net of debt discount of $73,811 and $132,254), respectively		53,412			22,968
Total long-term liabilities		79,611			154,458
Total liabilities		5,519,778			2,798,266
Commitment and contingencies		—			—
Stockholders' deficit
Preferred stock - $0.001 par value, authorized - 20,000,000 shares;
Series A Convertible Preferred stock - $0.001 par value, 12,000,000 shares designated; issued and outstanding - 12,000,000 and 12,000,000 shares, respectively		12,000			12,000
Series B Preferred stock - $0.001 par value, 70,000,000 shares designated; issued and outstanding 65,398,334 and 65,398,334 shares, respectively		65,398			65,398
Common stock - $0.001 par value, authorized - 900,000,000 shares; issued and outstanding – 181,985,547 and 74,045,606 shares, respectively		181,986			74,046
Common stock to be issued		13,500			13,500
Additional paid-in capital		6,912,652			6,259,050
Accumulated deficit		(11,156,906	)		(8,471,350	)
Total stockholders' deficit		(3,971,370	)		(2,047,355	)
Total liabilities and stockholders' deficit	$	1,548,409		$	750,911

See accompanying notes to the unaudited condensed consolidated financial statements

F-1

ALKAME HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
	For the three months ended						For the nine months ended
	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
Revenues	$	199,320		$	6,665		$	800,571		$	105,676
Cost of goods sold		231,596			33,717			691,499			129,340
Gross profit (loss)		(32,276	)		(27,052	)		109,072			(23,664	)
Operating expenses:
Selling expenses		128,129			242,935			571,415			642,800
General and administrative		359,412			110,359			899,960			261,129
Depreciation and amortization		26,272			711			110,206			2,133
Impairment of goodwill		658,187			—			658,187			—
Impairment of customer list		218,750			—			218,750			—
Total operating expenses		1,390,750			354,005			2,458,518			906,062
Loss from operations		(1,423,026	)		(381,057	)		(2,349,446	)		(929,726	)
Other Income / (Expenses):
Amortization of deferred financing costs		(11,441	)		(18,549	)		(74,810	)		(34,799	)
Interest expense		(57,660	)		(1,032,993	)		(133,082	)		(1,073,546	)
Amortization of beneficial conversion feature		(161,324	)		(46,845	)		(628,111	)		(46,845	)
Gain on change in fair value of derivative liability		347,251			374,363			499,266			374,363
(Loss) gain on settlement of debt		(104	)		—			627			—
Total other income (expenses)		116,722			(724,024	)		(336,109	)		(780,826	)
Net loss applicable to common stock holders	$	(1,306,304	)	$	(1,105,081	)	$	(2,685,556	)	$	(1,710,552	)
Per share data
Net Loss per share - basic and diluted	$	(0.01	)	$	(0.02	)	$	(0.02	)	$	(0.02	)
Weighted average number of shares outstanding- basic and diluted		169,231,116			70,558,287			137,263,440			76,557,282

See accompanying notes to the unaudited condensed consolidated financial statements

F-2

ALKAME HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
	For the Nine months ended
	September 30, 2015			September 30, 2014
Cash flows from operating activities:
Net loss	$	(2,685,556	)	$	(1,710,552	)
Adjustments to reconcile net loss to net cash
used in operating activities:
Bad debts		125,000			3,000
Depreciation and amortization		127,021			2,401
Impairment of intangible assets		876,937			—
Amortization of beneficial conversion feature		628,111			46,845
Gain on change in fair value of derivative liability		(499,266	)		(374,363	)
Amortization of prepaid assets		253,000			472,000
Amortization of deferred financing costs		74,810			34,799
Non-cash interest expense		—			1,001,280
Changes in operating asset and liability account balances:
Accounts receivable		(93,750	)		(69,801	)
Accounts receivable - others		24,056			—
Deposits		—			15,032
Inventory		(27,434	)		(14,064	)
Prepaid expenses		—			(10,000	)
Accrued interest		110,826			64,769
Accounts payable and accrued expenses		524,871			228,773
Total adjustments		2,124,182			1,400,671
Net cash used in operating activities		(561,374	)		(309,881	)
Cash flows from investing activities
Payment of purchase consideration to Xtreme Technologies, Inc.		(45,100	)		(50,000	)
Cash acquired from Xtreme Technologies, Inc.		13,287			—
Funds spent on potential Joint Venture		(12,130	)		—
Purchase of equipment		(43,395	)		(7,168	)
Net cash used in investing activities		(87,338	)		(57,168	)
Cash flows from financing activities:
Proceeds from officer loans		22,967			—
Payment of financing costs		(26,893	)		(39,250	)
Proceeds from notes payable		171,515			100,000
Payments of notes payable		(44,691	)		(7,000	)
Proceeds from convertible notes		353,833			346,750
Net cash provided by financing activities		476,731			400,500
Net (decrease) increase in cash		(171,981	)		33,451
Cash at beginning of period		172,730			128,258
Cash at end of period	$	749		$	161,709
Supplemental Schedule of Cash Flow Information:
Cash paid for interest	$	15,100		$	—
Cash paid for income taxes	$	—		$	—
Supplemental Schedules of Noncash Investing and Financing Activities:
Conversion of notes payable and accrued interest into common stock	$	314,653		$	—
Common stock issued to settle accounts payable	$	446,889		$	—
Payment made by EROP to noteholders on Company's behalf	$	318,000		$	—
Assets taken over and liabilities assumed from Xtreme Technologies, Inc.	$	2,050,000		$	—
Conversion of common shares in Series B convertible preferred stock	$	—		$	65,211
Beneficial conversion feature on convertible debt	$	353,832		$	1,348,030
Common stock issued for deferred financing cost	$	—		$	625,000
Amortization of equity deferred financing cost to additional paid-in capital	$	—		$	26,042

See accompanying notes to the unaudited condensed consolidated financial statements

F-3

Alkame Holding, Inc. and Subsidiaries

Notes to the Unaudited Condensed Consolidated Financial Statements

For the nine months ended September 30, 2015 and 2014

1. Organization and Nature of Operations

Alkame Holdings, Inc. (the "Company", “we”, “us” or “our”) was incorporated under the laws of the State of Nevada on April 19, 2010. 

The Company is in the business of distributing bottled/canned alkaline, antioxidant and oxygenated water.

On June 24, 2013, the Company entered into a share exchange agreement with Alkame Water, Inc. (“Alkame”) and the shareholders of all of the issued and outstanding shares of Alkame. On June 25, 2013, the Company acquired 100% of the members’ shares of Alkame, a Company incorporated in the state of Nevada on March 1, 2012, in exchange for 150,000,000 common shares, comprised of 116,666,667 common shares privately transacted from the President of Company and the issuance of 33,333,333 common shares to shareholders of Alkame. Effectively, Alkame held 71% of the issued and outstanding common shares of the Company and the transaction has been accounted for as a reverse merger, where Alkame is deemed to be the acquirer and or the surviving entity for accounting purposes.

As part of the acquisition transaction, all assets and liabilities of Alkame Holdings, Inc. at the date of acquisition were assumed by the former management.

The transaction is accounted for using the purchase method of accounting. As a result of the recapitalization and change in control, Alkame is the acquiring entity in accordance with ASC 805, Business Combinations. Accordingly, the historical financial statements are those of Alkame, the accounting acquirer, immediately following the consummation of the reverse merger.

Stock Purchase Definitive Agreement with Xtreme Technologies, Inc.

On April 21, 2014, the Company entered into a Stock Purchase Definitive Agreement with Xtreme Technologies, Inc., an Idaho corporation. In accordance with the terms of the Agreement, the Company will purchase all of the outstanding shares of Xtreme for the purchase price of $2,050,000.00, payable as follows:

· An initial cash deposit of $50,000 was converted into a non-refundable payment to extend the closing date;

· An additional $50,000 deposit payment was made at the date of extension;

· An additional cash payment of $525,000 shall be paid on or before the Closing Date (defined below), which, along with the additional $50,000 deposit, shall pay specific obligations on Xtreme’s balance sheet;

· As amended per agreement on December 9, 2015, the balance of $1,425,000.00 shall be payable by the issuance of shares of the Company’s Series C Preferred Stock with a stated value of $1.00 per share to be divided pro rata among the Company’s shareholders of record as of the Closing Date. The Series C Preferred Stock includes an option to convert such shares of Series C Preferred Stock into the Company’s Common Stock at the market price on the day prior to conversion; and

· One of Xtreme’s previous officers and directors holds outstanding options to purchase up to 1,009,000 shares of Xtreme’s common stock at the price of $0.10 per share. At the Closing Date, pursuant to Idaho law, Xtreme shall notify this previous officer and director of his 30-day right to exercise any or all of his remaining options. If he elects to exercise any of his options within such 30-day period, the Company agrees to issue additional shares of Series C Preferred Stock in exchange for such Xtreme shares.

o After proper notice, the holder permitted the options to expire unexercised.

The following amendments were entered in relation the Xtreme acquisition:

1. Effective January 16, 2015, the sellers of Xtreme were given the option to rescind and terminate the transaction if the debt was not paid within 120 days of the closing date.

2. Effective April 15, 2015, the 120-day deadline was extended to 240 days after the closing date. Such deadline will be automatically extended by additional 30 day increments, provided that payments from EROP have been made to escrow within 60 days of the 240-day expiration period.

F-4

3. Effective December 9, 2015, the securities deliverable to the sellers of Xtreme was amended from Series B Preferred Stock to Series C Preferred Stock.

On January 13, 2015, the Company completed the acquisition of Xtreme Technologies, Inc., an Idaho corporation.

Under the Agreement, Amendment, and Second Amendment, Xtreme became our wholly-owned subsidiary and we acquired the patents on the proprietary process that we believe is the most technologically advanced in water treatment systems for complete hydration. We assumed the operations of Xtreme and continue its business of distributing technologically enhanced bottled water.

Upon closing of the acquisition, we discovered that Xtreme was operating at a loss for the prior year and that it required a substantial cash infusion. We have begun a program of upgrading the production line, reorganized personnel, and began an effort to increase sales of the division so that it returns to profitability as quickly as possible.

Our primary objective now is to introduce, promote, aggressively market and establish channels of distribution to sell our product to a wide range of consumers, first in the United States, Canada and Mexico, and then globally.

We believe that holding the patents will enable us to enhance our position in the investment community, allow us to expand our reach in the distribution of product, and provide us access to other applications the water treatment technology has available. We are exploring other uses of our water so that we can diversify our portfolio of products to include other specialty uses outside of the bottled water and health water markets.

The Company’s fiscal year end is December 31.

2. Going Concern

These accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. For the nine months ended September 30, 2015, the Company recognized $800,571 in revenue, and as of September 30, 2015 had an accumulated deficit of $11,156,906. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing, and generating profitable operations from the Company’s future operations. However, there can be no assurance that these arrangements will be sufficient to fund its ongoing capital expenditures, working capital, and other cash requirements. The outcome of these matters cannot be predicted at this time. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These accompanying unaudited condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

3. Basis of Presentation

These unaudited interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) for financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for any interim period or an entire year. The Company applies the same accounting policies and methods in its interim financial statements as those in the most recent audited annual financial statements. The financial statements and notes included herein should be read in conjunction with the annual financial statements and notes for the year ended December 31, 2014 included in the Company’s filing on Form 10-K.

The financial statements of the Company have been prepared in accordance with US GAAP and are expressed in U.S. dollars. All inter-company accounts and transactions have been eliminated. The Company’s fiscal year end is December 31.

F-5

4. Summary of Significant Accounting Policies

a)   Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

b) Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries Alkame Water, Inc. and Xtreme Technologies, Inc. All significant inter-company transactions are eliminated.

c)   Cash and Cash Equivalents

For purposes of the statement of cash flows, cash includes demand deposits, saving accounts and money market accounts. The Company considers all highly liquid instruments with maturities of three months or less when purchased to be cash equivalents.

d) Accounts receivable and concentration of credit risk

Because the Company currently uses distributors as their main source of product sales and placement, there is an inherent risk that the distributor could experience difficulty in their payments for accounts they ship to. The result, may be that they, while collecting from the stores and chains they supply, they do not process through the payments to us. Although in the past the Company did see significant credit risk associated with the trade receivables, repayment is dependent upon the financial stability of the various distributors and customers to which shipment takes place. As a result, the Company is looking more closely at the credit worthiness of its customer and how large a footprint and customer base various distributors have, and is attempting to limit how much of our business is conducted through any one customer or distributor. Our concentration risk is being reevaluated on a quarterly basis.

e) Allowance for doubtful accounts

The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts and the aging of the accounts receivable.  The Company regularly reviews the adequacy of the Company’s allowance for doubtful accounts through identification of specific receivables where it is expected that payments will not be received.  The Company also establishes an unallocated reserve that is applied to all amounts that are not specifically identified.  In determining specific receivables where collections may not have been received, the Company reviews past due receivables and gives consideration to prior collection history and changes in the customer’s overall business condition.  The allowance for doubtful accounts reflects the Company’s best estimate as of the reporting dates.

At September 30, 2015 and December 31, 2014, the Company had an allowance for bad debts in the amount of $148,000 and $23,000 respectively.

f) Basic and Diluted Net Loss per Share

The Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS

F-6

is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. Such securities, shown below, presented on a common share equivalent basis and outstanding as of September 30, 2015 and 2014 have been excluded from the per share computations:

	As of
	September 30, 2015		September 30, 2014
Series A Convertible Preferred Stock		600,000,000		600,000,000
Series B Convertible Preferred Stock		65,398,334		65,210,834
Series C Convertible Preferred Stock		356,250,000		—
Convertible notes payable		356,576,614		5,862,185
Warrants		1,587,302		—
EROP conversion of debt		136,543,519		—

g) Financial Instruments

Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2015, with the exception of its convertible notes payable. The carrying amounts of these liabilities at September 30, 2015 approximate their respective fair value based on the Company’s incremental borrowing rate.

Cash is considered to be highly liquid and easily tradable as of September 30, 2015 and therefore classified as Level 1 within our fair value hierarchy.

In addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments

h) Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

F-7

Professional standards generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.  Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt Instrument”.

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

i) Derivative Liabilities

The Company assessed the classification of its derivative financial instruments as of March 31, 2015, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

j) Income Taxes

Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740 “Accounting for Income Taxes” as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in this financial statement because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.

k) Revenue Recognition

The Company recognizes revenue in accordance with ASC-605, “Revenue Recognition,” which requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or title has passed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts.

F-8

Revenues are recognized upon shipment, provided that a signed purchase order has been received, the price is fixed, title has transferred, collection of resulting receivables is reasonably assured, and there are no remaining significant obligations. Reserves for sales returns and allowances, including allowances for so called “ship and debit” transactions, are recorded at the time of shipment, based on historical levels of returns and discounts, current economic trends and changes in customer demand. Certain Internet generated transactions that are prepaid at time of order, are recognized at the time the merchandise ships from the warehouse to the customer.

Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

l) Reclassification

Certain reclassifications have been made to conform the prior period data to the current presentation. These reclassifications had no effect on reported net loss.

5. Notes Payable

Notes Payable to Stockholders:

The Company owed $38,199 and $43,490 at September 30, 2015 and December 31, 2014 respectively to a stockholder. 

During the year ended December 31, 2013, the Company had $63,000 in expenses paid on its behalf by this shareholder which was recorded as a Note. On August 1, 2013, the Company and note holder amended the Note by mutual agreement increasing the principal amount by an additional $10,000 for other services rendered by the former director.  The Note is unsecured, and begin accruing interest August 1, 2014 at 5% per annum on the unpaid principal thereafter.  Based on a repayment agreement that calls for monthly payments of $1,000 per month.

During the nine months ended September 30, 2015 and 2014, the Company repaid $8,000 ($5,291 principal and $2,709 accrued interest) and $7,000 of the Note, respectively.  

Notes Payable to Xtreme Shareholders:

In January 2015, an accredited investor group, EROP, filed and received approval by the courts for a 3(a)10 filing under which they acquired various debts, including the note due to the former shareholders of Xtreme Technologies, Inc. Under terms of the court order, they are able to convert the debts into common shares of the Company at a 40% discount to the market.

The original balance acquire was $525,000. As of September 30, 2015 the balance is $207,000.

Notes Payable, others:

On March 29, 2013, the Company entered into a two-year promissory note agreement for $500,000. On April 8, 2013, the Company received $200,000 and on May 1, 2013, the Company received $300,000. On September 27, 2013, the note agreement was amended to include an additional advance to the Company of $250,000.  Pursuant to the agreement, the loan is secured with a general security agreement, bears interest at 10% per annum, and $500,000 is due on March 30, 2015 and $250,000 is due on September 27, 2015. These notes are currently in technical default. To date, the lender has not declared a default, and continues to forebear on collection.

On March 11, 2014, the Company entered into an additional two-year promissory note agreement for an additional $100,000 from the same investor group, on the same terms as outlined above.

F-9

At September 30, 2015 and December 31, 2014, the Company has accrued interest of $183,625 and $119,875, respectively. The original note, and the amendment, each mature two years from date of issuance or amendment.

At September 30, 2015, the Company classified $850,000 of this note payable as current liability.

The Company paid 10% of proceeds from $750,000 of the long-term notes payable as financing cost of $75,000 to a consultant. The Company will amortize this cost over the term of the long-term note payable.

The Company paid 10% of proceeds from the $100,000 long-term notes payable as financing cost of $10,000 to a consultant. The Company will amortize this cost over the term of the long-term note payable.

During the nine months ended September 30, 2015 and 2014, the Company charged to operations $74,810 and $34,799 as amortization of deferred financing costs, respectively. As of September 30, 2015 and December 31, 2014, remaining balance in deferred financing cost of $11,898 and $63,375, respectively and is presented as part of other assets.

In July 2015, the Company borrowed $70,000 from an accredited investor group on a term loan. The note carries interest at 15% per annum and requires repayment of a total of $98,000 through daily payments of $560.

In July 2015, the Company borrowed $25,000 from an accredited investor group on a term loan. The note carries prepaid interest of 10% of the amount borrowing.

In August 2015, the Company borrowed $50,000 from an accredited investor group on a term loan. The note carries interest at 15% per annum and requires repayment of a total of $74,500 through daily payments of $899.

6. Convertible debt

At September 30, 2015 and December 31, 2014 convertible notes and debentures consisted of the following:

	September 30, 2015			December 31, 2014
Convertible notes payable	$	663,222		$	604,472
Unamortized debt discount		(138,264	)		(412,543	)
Carrying amount	$	524,958		$	191,929
Less: current portion		(471,546	)		(168,962	)
Long-term convertible notes, net	$	53,412		$	22,968

Note issued on August 6, 2014, fully converted:

On August 6, 2014, the Company entered into a one-year convertible debenture for $82,500 with an accredited institutional investor. The debenture was convertible at the lesser of $0.10 per share, or 60% of the lowest trade price in the 25 trading days prior to conversion. The note was issued with an original issue discount of $7,500 which was charged to current period operations as interest expense during the year ended December 31, 2014.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in August 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $190,451 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	105	%
Risk free rate:	0.48	%

F-10

The initial fair values of the embedded debt derivative of $190,451 was allocated as a debt discount up to the proceeds of the note ($82,500) with the remainder ($107,951) charged to operations as derivative liability adjustment in during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $17,187 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized the remaining $65,313 to the current period operations as amortization of beneficial conversion feature upon full conversion of the debenture.

At September 30, 2015, due to full conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash, non-operating gain of $142,317 for the nine months ended September 30, 2015.

Note issued on August 6, 2014, fully converted:

On August 6, 2014, the Company entered into a nine-month convertible debenture for $68,000 with an accredited institutional investor. The debenture is convertible at 58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in August 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $94,657 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	105	%
Risk free rate:	0.48	%

The initial fair values of the embedded debt derivative of $94,657 was allocated as a debt discount up to the proceeds of the note ($68,000) with the remainder ($32,145) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $37,778 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized the remaining $30,222 to the current period operations as amortization of beneficial conversion feature upon full conversion of the debenture.

At September 30, 2015, due to full conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash, non-operating gain of $90,253 for the nine months ended September 30, 2015.

Note issued on August 11, 2014, fully converted:

On August 11, 2014, the Company entered into a five-month convertible debenture for $45,000 with an accredited institutional investor. The debenture is convertible at 50% of the lowest traded price in the 20 days prior to the conversion.

F-11

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in August 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $131,493 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	111	%
Risk free rate:	0.05	%

The initial fair values of the embedded debt derivative of $131,493 was allocated as a debt discount up to the proceeds of the note ($45,000) with the remainder ($86,493) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $37,500 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized the remaining $7,500 to the current period operations as amortization of beneficial conversion feature upon full conversion of the debenture.

At September 30, 2015, due to full conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash, non-operating gain of $58,401 for the nine months ended September 30, 2015.

Note issued on September 4, 2014, fully converted:

On September 4, 2014, the Company entered into a nine-month convertible debenture for $42,500 with an accredited institutional investor. The debenture is convertible at 58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in September 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $52,597 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	131	%
Risk free rate:	0.48	%

The initial fair values of the embedded debt derivative of $52,597 was allocated as a debt discount up to the proceeds of the note ($42,500) with the remainder ($10,097) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $18,889 to current period operations as amortization beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized the remaining $23,611 to the current period operations as amortization of beneficial conversion feature upon full conversion of the debenture.

At September 30, 2015, due to full conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash, non-operating gain of $59,207 for the nine months ended September 30, 2015.

F-12

Note issued on September 5, 2014:

On September 5, 2014, the Company entered into a one-year convertible debenture for $52,500 with an accredited institutional investor. The debenture is convertible at 53% of the lowest trading price in the 20 trading days prior to the conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in September 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $578,343 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	166	%
Risk free rate:	0.10	%

The initial fair values of the embedded debt derivative of $578,343 was allocated as a debt discount up to the proceeds of the note ($52,500) with the remainder ($525,843) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $17,500 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized $35,000 to current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $73,499 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.0001	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $16,678 for the nine months ended September 30, 2015.

Note issued on September 11, 2014, fully converted:

On September 11, 2014, the Company entered into a nine-month convertible debenture for $56,250 with an accredited institutional investor. The debenture is convertible at 55% of the average of the two lowest trading price in the 25 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in September 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $300,489 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	240	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $300,489 was allocated as a debt discount up to the proceeds of the note ($56,250) with the remainder ($244,239) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

F-13

During the year ended December 31, 2014, the Company amortized $25,000 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized the remaining $31,250 to the current period operations as amortization of beneficial conversion feature upon full conversion of the debenture.

At September 30, 2015, due to full conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash, non-operating gain of $84,645 for the nine months ended September 30, 2015.

Note issued on October 24, 2014:

On October 24, 2014, the Company entered into a twelve-month convertible debenture for $55,000 with an accredited institutional investor. The debenture is convertible at 60% of the lowest closing price in the 20 trading days prior to conversion. The note was issued with an original issue discount of $5,000 which was recorded as part of deferred financing cost and amortized over the term of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in October 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $162,550 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions: 

Dividend yield:	0	%
Volatility	260	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $162,550 was allocated as a debt discount up to the proceeds of the note ($55,000) with the remainder ($107,550) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $13,750 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized $41,250 to current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $50,792 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.0001	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $34,423 for nine months ended September 30, 2015.

Note issued on October 27, 2014 – Long Term:

On October 27, 2014, the Company entered into a two-year convertible debenture for $33,000 with an accredited institutional investor. The debenture is convertible at lesser of (a) $0.15 or (b) 60% of the lowest trading price in the 25 trading days prior to conversion. The note was issued with an original issue discount of $3,000 which was recorded as part of deferred financing cost and amortized over the term of the note.

F-14

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in October 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $100,870 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions: 

Dividend yield:	0	%
Volatility	260	%
Risk free rate:	0.41	%

The initial fair values of the embedded debt derivative of $100,870 was allocated as a debt discount up to the proceeds of the note ($33,000) with the remainder ($67,870) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $4,125 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized $12,375 to current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $53,565 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.33	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $4,182 for the nine months ended September 30, 2015.

Note issued on October 29, 2014:

On October 29, 2014, the Company entered into a twelve-month convertible debenture for $55,000 with an accredited institutional investor. The debenture is convertible at lesser of (a) $0.10 or (b) 60% of the lowest trading price in the 25 trading days prior to conversion. The note was issued with an original issue discount of $5,000 which was recorded as part of deferred financing cost and amortized over the term of the note.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in October 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $142,870 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions: 

Dividend yield:	0	%
Volatility	260	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $142,870 was allocated as a debt discount up to the proceeds of the note ($55,000) with the remainder ($87,870) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $13,750 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized $41,250 to current period operations as amortization of beneficial conversion feature.

F-15

The fair value of the described embedded derivative of $52,221 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.0001	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $33,270 for the nine months ended September 30, 2015.

Note issued on November 12, 2014:

On November 12, 2014, the Company entered into a twelve-month convertible debenture for $75,000 and a 5-year warrant to purchase an aggregate of 1,587,302 shares with an accredited institutional investor. The debenture is convertible at 50% of the lowest trading price in the 20 trading days prior to conversion. The warrant is exercisable at $0.24 per share subject to adjustments.

In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of nil of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature. The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in November 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $324,627 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	261-275	%
Risk free rate:	0.14	%

The initial fair values of the embedded debt derivative of $324,627 was allocated as a debt discount up to the proceeds of the note ($75,000) with the remainder ($249,627) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $4,795 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized $56,250 to current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $101,204 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.0001-1.37	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $94,135 for the nine months ended September 30, 2015.

Note issued on December 16, 2014 – Long Term:

On December 16, 2014, the Company entered into a two-year convertible debenture for $39,772 with an accredited institutional investor. The debenture is convertible at 60% of the lowest trading price in the 25 trading days prior to conversion.

F-16

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in December 2014.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $85,288 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions: 

Dividend yield:	0	%
Volatility	275	%
Risk free rate:	0.58	%

The initial fair values of the embedded debt derivative of $85,288 was allocated as a debt discount up to the proceeds of the note ($39,722) with the remainder ($45,566) charged to operations as derivative liability adjustment during the year ended December 31, 2014.

During the year ended December 31, 2014, the Company amortized $1,655 to current period operations as amortization of beneficial conversion feature.

During the nine months ended September 30, 2015, the Company amortized $14,895 to current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $64,323 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.33	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $5,665 for the nine months ended September 30, 2015.

Note issued on January 22, 2015:

On January 22, 2015, the Company entered into a twelve-month convertible debenture for $75,000 with an accredited institutional investor. The debenture is convertible at 55% of the lowest trading price in the 20 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in January 2015.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $210,982 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	335	%
Risk free rate:	0.41	%

The initial fair values of the embedded debt derivative of $210,982 was allocated as a debt discount up to the proceeds of the note ($75,000) with the remainder ($135,982) charged to operations as derivative liability adjustment during the nine months ended September 30, 2015.

During the nine months ended September 30, 2015, the Company amortized the $56,250 to the current period operations as amortization of beneficial conversion feature.

F-17

The fair value of the described embedded derivative of $97,161 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.0001	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $113,821 for the nine months ended September 30, 2015.

Note issued on January 29, 2015:

On January 29, 2015, the Company entered into a nine-month convertible debenture for $28,000 with an accredited institutional investor. The debenture is convertible at 58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in January 2015.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $46,247 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	336	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $46,247 was allocated as a debt discount up to the proceeds of the note ($28,000) with the remainder ($18,247) charged to operations as derivative liability adjustment during the nine months ended September 30, 2015.

During the nine months ended September 30, 2015, the Company amortized the $27,999 to the current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $23,754 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.0001	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $22,493 for the nine months ended September 30, 2015.

Note issued on February 9, 2015:

On February 9, 2015, the Company entered into a twelve-month convertible debenture for $108,000 with an accredited institutional investor. The debenture is convertible at 60% of the lowest trading price in the 20 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in February 2015.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $181,521 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

F-18

Dividend yield:	0	%
Volatility	336	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $181,521 was allocated as a debt discount up to the proceeds of the note ($108,000) with the remainder ($73,521) charged to operations as derivative liability adjustment during the nine months ended September 30, 2015.

During the nine months ended September 30, 2015, the Company amortized the $72,000 to the current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $141,415 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.08	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $40,106 for the nine months ended September 30, 2015.

Note issued on February 10, 2015 – Long Term:

On February 10, 2015, the Company entered into a twenty-four-month convertible debenture for $22,000 with an accredited institutional investor. The debenture is convertible at 60% of the lowest trading price in the 25 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in February 2015.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $41,170 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	336	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $41,170 was allocated as a debt discount up to the proceeds of the note ($22,000) with the remainder ($19,170) charged to operations as derivative liability adjustment during the nine months ended September 30, 2015.

During the nine months ended September 30, 2015, the Company amortized the $10,083 to the current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $37,011 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.33	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $4,159 for the nine months ended September 30, 2015.

F-19

Note issued on February 19, 2015:

On February 19, 2015, the Company entered into a twelve-month convertible debenture for $35,000 with an accredited institutional investor. The debenture is convertible at 50% of the lowest trading price in the 20 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in February 2015.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $53,829 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	336	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $53,829 was allocated as a debt discount up to the proceeds of the note ($35,000) with the remainder ($18,829) charged to operations as derivative liability adjustment during the nine months ended September 30, 2015.

During the nine months ended September 30, 2015, the Company amortized the $23,333 to the current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $57,479 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	282	%
Risk free rate:	0.08	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $3,650 for the nine months ended September 30, 2015.

Note issued on February 25, 2015 – Long Term:

On February 25, 2015, the Company entered into a two-year convertible debenture for $33,333 with an accredited institutional investor. The debenture is convertible at the lower of (a) $0.10 per share; or (b) 60% of the lowest trading price in the 25 trading days prior to conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in February 2015.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $61,358 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions: 

Dividend yield:	0	%
Volatility	340	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $61,358 was allocated as a debt discount up to the proceeds of the note ($33,333) with the remainder ($28,025) charged to operations as derivative liability adjustment during the nine months ended September 30, 2015.

During the nine months ended September 30, 2015, the Company amortized $11,112 to current period operations as amortization of beneficial conversion feature.

F-20

The fair value of the described embedded derivative of $56,299 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.33	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $5,059 for the nine months ended September 30, 2015.

Note issued on March 13, 2015:

On March 5, 2015, the Company entered into an eight-month convertible debenture for $52,500 with an accredited institutional investor. The debenture is convertible at 53% of the lowest trading price in the 20 trading days prior to the conversion.

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in March 2015.  These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $73,432 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:  

Dividend yield:	0	%
Volatility	343	%
Risk free rate:	0.11	%

The initial fair values of the embedded debt derivative of $73,432 was allocated as a debt discount up to the proceeds of the note ($52,500) with the remainder ($20,932) charged to operations as derivative liability adjustment during the nine months ended September 30, 2015.

During the nine months ended September 30, 2015, the Company amortized $30,625 to current period operations as amortization of beneficial conversion feature.

The fair value of the described embedded derivative of $64,625 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:

Dividend yield:	0	%
Volatility	280	%
Risk free rate:	0.0001	%

At September 30, 2015, the Company adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $8,807 for the nine months ended September 30, 2015.

7. Fair Value of Financial Instruments

ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value: 

F-21

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement.  

Items recorded or measured at fair value on a recurring basis in the accompanying unaudited condensed consolidated financial statements consisted of the following items as of September 30, 2015:

			Fair Value Measurements at  September 30, 2015 using:
	September 30, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Derivative Liabilities	$	873,348		—		—	$	873,348

The debt derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors based on historical prices for the Company’s common stock and are classified within Level 3 of the valuation hierarchy. 

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of September 30, 2015:

		Derivative Liability
Balance, December 31, 2014	$	1,018,782
Additions		668,537
Change in fair value of derivative liabilities		(813,971	)
Balance, September 30, 2015	$	873,348

8. Related Party Transactions

During the nine months ended September 30, 2015 and 2014, the Company received $22,967 and $0, respectively, in cash loans, and made cash payments on these amounts owing totaling $0 and $0 during the same periods. 

As of September 30, 2015 and December 31, 2014, the Company owed $26,456 and $3,489, to its President. The amounts owing are unsecured, non-interest bearing and due on demand.

As of September 30, 2015 and December 31, 2014, the Company owes $210,000 and $120,000, respectively to Kaufman & Associates (holding more than 5% shares of the Company) in connection with a consulting agreement.

F-22

9. Stockholders’ Deficit

Where applicable, all common share numbers have been restated to retroactively reflect, the 1:3 reverse split affected by the Company on January 8, 2014.

a) Authorized

Authorized capital stock consists of:

· 900,000,000 common shares with a par value of $0.001 per share; and

· 100,000,000 preferred shares with a par value of $0.001 per share;

o The Company has designated 12,000,000 shares as Series A Convertible Preferred Series Stock. Each share of Series A Preferred Stock is convertible into fifty (50) shares of Common Stock.

o The Company has designated 70,000,000 shares as Series B Convertible Preferred Series Stock. Each share of Series B Preferred Stock is convertible into one (1) share of Common Stock.

o The Company has designated 10,000,000 shares as Series C Convertible Preferred Series Stock. Each share of Series C Preferred Stock is convertible into $1.00 of Common Shares at the market price on the date of conversion.

Increase in authorized shares

On January 24, 2014, the Company filed a Certificate of Amendment to the Company’s Articles of Incorporation (the “Certificate of Amendment”) with the Nevada Secretary of State. The Certificate of Amendment amends Article III of the Company’s Articles of Incorporation to authorize the issuance of up to one hundred million (100,000,000) shares of Preferred Stock, par value $0.001 per share, which may be issued in one or more series, with such rights, preferences, privileges and restrictions as shall be fixed by the Company’s Board of Directors from time to time. As a result of the Certificate of Amendment, we now have one billion (1,000,000,000) authorized shares, par value $0.001 per share, consisting of two classes designated as “Common Stock” and “Preferred Stock.” The total number of shares of Common Stock that we have authority to issue is nine hundred million (900,000,000) shares and the total number of shares of Preferred Stock that we have authority to issue is one hundred million (100,000,000) shares. The Company’s Board of Directors and a majority of our shareholders approved the Certificate of Amendment.

Series B Convertible Preferred Stock

On January 24, 2014, pursuant to Article III of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock entitled Series B Preferred Stock, consisting of up to seventy million (70,000,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series B Preferred Stock will participate on an equal basis per-share with holders of our common stock and Series A Preferred Stock in any distribution upon winding up, dissolution, or liquidation. Holders of Series B Preferred Stock are entitled to convert each share of Series B Preferred Stock into one (1) share of common stock. Holders of Series B Preferred Stock are also entitled to vote together with the holders of our common stock and Series A Preferred Stock on all matters submitted to shareholders at a rate of one (1) vote for each share held.

The rights of the holders of Series B Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on January 24, 2014.

Series C Convertible Preferred Stock

On January 24, 2014, pursuant to Article III of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock entitled Series C Preferred Stock, consisting of up to ten million (10,000,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series C Preferred Stock will be entitled to receive the Stated Value per share ($1.00) in any distribution upon winding up, dissolution, or liquidation. Holders of Series C Preferred Stock are entitled to convert such number of shares of Common Stock equal to the quotient of the Stated Value per share divided by the closing price of our common stock on the day of conversion. Holders of Series C Preferred Stock are also entitled to vote together with the holders of our common stock, Series A Preferred Stock and Series B Preferred Stock on all matters submitted to shareholders at a rate of one (1) vote for each share held.

The rights of the holders of Series C Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on January 24, 2014.

F-23

b) Share Issuances

On January 28, 2014, six stockholders exchanged a total of 65,210,834 common shares for 65,210,834 Series B Convertible Preferred Stock.

On January 12, 2015, the Company issued 3,600,000 common shares at an average price of $0.01926 per share to an accredited investor group in settlement of $69,336 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In February 2015, the Company issued 6,500,000 common shares at a price of $0.01706 per share to an accredited investor group in settlement of $110,910 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In February 2015, the Company issued 13,365,052 common shares at an average price of $0.01291 per share upon conversion by the holders of $166,970 of convertible debentures and $5,557 of accrued interest.

In March 2015, the Company issued 16,100,000 common shares at a price of $0.00426 per share to an accredited investor group in settlement of $68,508 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In March 2015, the Company issued 24,373,736 common shares at an average price of $0.0108 per share upon conversion by the holders of $138,113 of convertible debentures and $4,013 of accrued interest.

In April 2015, the Company issued 6,000,000 common shares at a price of $0.0024 per share to an accredited investor group in settlement of $14,400 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In May 2015, the Company issued 7,400,000 common shares at a price of $0.0042 per share to an accredited investor group in settlement of $29,748 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In June 2015, the Company issued 10,118,865 common shares at a price of $0.00698 per share to an accredited investor group in settlement of $70,613 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In August 2015, the Company issued 8,000,000 common shares at a price of $0.00335 per share to an accredited investor group in settlement of $26,800 of accounts and notes payable they had previously acquired from the various debt holders, and an additional 7,000,000 common shares at a price of $0.003 per share to the same accredited investor group in settlement of $21,000 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In September 2015, the Company issued 5,482,288 common shares at a price of $0.00198 per share to an accredited investor group in settlement of $10,855 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

As of September 30, 2015 and December 31, 2014, there were 181,985,547 and 74,045,606 shares of common stock issued and outstanding, respectively.  

10. Commitments and Contingencies

Litigation

In April 2014, we were notified that a note holder disputes the balance of his note as recorded on the books of our company. The discrepancy arises from a question regarding expenses that the holder claims were paid on behalf of our company and subsequent payments that we recorded as payments against the note. We have no record of the expenses claimed to be due, and we are in negotiations to settle this matter. We have accrued $28,000 to cover the potential expenses and adjustments to accrued interest if the claim is substantiated. We believe it has properly accounted for all payments made to the individual and have provided documentation to him substantiating our position.

F-24

Renard Wigginsetal.v.AlkameHoldings,Inc.etal.,casenumberA-14-700799- C, Eighth Judicial District Court, Clark County,Nevada (the "Wiggins Lawsuit"). Renard Wiggins fileda Complaint on May 15, 2014, against the Company and Robert Eakle, asserting claims for breaches of contracts, tortious and contractual breachesof implied covenants of good faith and fair dealing, breaches of fiduciary duties, conversion, and unjust enrichment, and seeking damages in excess of $10,000, as wellas declaratory and injunctive relief, in connection with purported stock and royalty agreements from or before June of 2012, between the plaintiff and Alkame Water, Inc.

 After successive motions to dismiss, on February 18, 2015, the Wiggins Lawsuit was amended, with the addition of Alkaline Royalty Corp. as a co-plaintiff, and the scope of claims asserted in their Second Amended Complaint was narrowed, with the dismissal of Robert Eakle and leaving remaining claims against the Company for non-tort breaches of contract with damages in excess of $10,000 and declaratory and injunctive relief in connection with the purported stock and royalty agreements. Among other things, the plaintiffs request "declaratory judgment that it is entitled to the shares, ownership or equity in Alkame Holdings reflecting the 20% stake in Alkame Water he should have received pursuant to the Stock Agreement and/or any proceeds which would have resulted had he received those shares or equity stake in Alkame Water prior to the merger with Pinnacle ass promised and that he is entitled to his royalty payments."

The discovery period was extended to the end of December, with trial scheduled for the end of February 2016. The parties continue to be engaged in settlement discussions that may or may not prove fruitful. Absent an acceptable settlement, theCompanyintends tovigorously defend against theplaintiffs' claims. Itistoo early to evaluate withany certainty the likely outcome of the litigation initiated by the plaintiffs. In February 2016, the Company engaged new counsel and the trial originally scheduled for February 2016, is now scheduled for March 2016.

The Company may, from time to time, become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. The Company is currently not aware of any such legal proceedings that it believes will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results.

Commitments

In July 2015, the Company terminated the employment agreements with Keith Fuqua and Timm Ott. Under the terms of the agreements, the Company will continue to make severance payments and provide health insurance through January 2016.

11. Acquisition of Xtreme Technologies, Inc.

On January 13, 2015, the Company purchased one hundred percent (100%) of the shares of Xtreme Technologies, Inc. The aggregate purchase price was $2,050,000, paid as follows: (i) cash of $100,000; (ii) 1,425,000 restricted Preferred Series C stock shares valued at $1.00 per share, totaling $1,425,000; (iii) an unsecured promissory note of $525,000. This transaction was accounted for under the purchase method in accordance with ASC 805.

In connection with the Xtreme Technologies, Inc. acquisition, the Company identified and recognized intangible assets of $1,400,000 representing patents, trade names, and customer relationships. The assets were being amortized on a straight line basis over their estimated life of seven (7) years for the patents, and three (3) years for the trade names and customer relationships. This resulted in the sum of the future net cash flows discounted to its present day value. The valuation provided for the patents, trade name, and customer relationships was based on management’s calculations. During the nine months ended September 30, 2015 and 2014, the Company recognized amortization expense of $103,571 and $0, respectively. The Company will recognize amortization expense of $24,107 in the remainder of fiscal year ending 2015, $192,857 in the fiscal year ending 2016, $192,857 in the fiscal year ending 2017, $167,857 in the fiscal year ending 2018, and $142,857 each year in the fiscal years 2019 through 2024 and $71,429 in the fiscal year ending 2025. At September 30, 2015, the Intangible asset balance, net of accumulated amortization and impairment, is $1,077,679.

F-25

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:

ASSETS:
Current assets	$	144,112
Property & equipment		91,431
Intangible assets		1,400,000
Goodwill		658,187
Total	$	2,293,730
LIABILITIES:
Current liabilities	$	243,730
Net purchase price	$	2,050,000

In the third quarter of 2015, the Company determined that the goodwill and the balance of the unamortized customer list should be written down to zero value. As a result, the Company recorded a total impairment to the intangible assets of $876,937.

Purchase Price Allocation

In accordance with ASC 805, Business Combinations, the Company recorded the assets acquired and liabilities assumed at their respective estimated fair values as of the acquisition date. The total estimated purchase prices were allocated to the assets acquired and liabilities assumed based on their estimated fair values. The fair value allocation is preliminary and is subject to change based on evaluations of the assets to be performed by the Company.

The following unaudited pro forma consolidated results of operations have been prepared, as if the acquisition had occurred as of January 1, 2014: 

	Nine months ended September 30,
	2015			2014
	(Unaudited)			(Unaudited)
Revenue	$	804,676		$	989,844
Net loss from continuing operations	$	(1,792,303	)	$	(1,658,811	)
Net loss per share from continuing operations	$	(0.01	)	$	(0.02	)
Weighted average number of common stock shares – Basic and diluted		181,985,547			74,045,606

Series C Convertible Preferred Stock to be issued:

During the nine months ended September 30, 2015, the Company committed to issue 1,425,000 shares of Series C Preferred stock valued at $1.00 per share as part of Stock Purchase Agreement entered into with Xtreme Technologies, Inc.

12. Subsequent Events

We have evaluated subsequent events through the date of issuance of the unaudited condensed consolidated financial statements, and did not have any material recognizable subsequent events, other than the following:

In November 2015, the Company issued 9,000,000 common shares at a price of $0.00192 per share to an accredited investor group in settlement of $17,280 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

F-26

In November 2015, the Company designated a Series D Preferred Stock consisting of four million (4,000,000) shares, par value $0.001. The series is convertible into common stock of the Company at a conversion of ten (10) shares of common stock for every Series D Preferred Stock. In addition, holders of the series can vote in matters submitted for vote by the shareholders at the rate of twenty-five thousand (25,000) votes for each share held. Additional rights of the holders of the Series D Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on November 25, 2015 and as Exhibit 3.1 to Form 8-K filed on November 30, 2015.

In November 2015, the Company, retroactively entered into an employment agreement with Robert Eakle our executive officer and director for the year ended December 31, 2015. Simultaneously, the Company retroactively entered into a consulting agreement with Kaufman & Associates, Inc. Under the terms of the agreements, each will receive annual compensation of $120,000 and receive 1,000,000 shares of our newly created Series D Preferred Stock. Additional information and details of the agreements can be found in the agreements filed as Exhibits 10.1 and 10.2 to Form 8-K filed on November 30, 2015.

In December 2015, the Company issued 7,500,000 common shares at a price of $0.0024 per share to an accredited investor group in settlement of $18,000 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

As previously reported, on January 22, 2015, the Company entered into a binding Memorandum of Understanding to form a joint venture (the “MOU”) with Read Made, Inc. The purpose of the joint venture is to develop intellectual property associated with single use disposable baby bottles and market the completed products in the US and international markets.

It has been brought to the Company’s attention that Ready Made has signed a new agreement, without any formal termination of the existing MOU. The Company has decided to announce its formal rescission from the MOU, due to the inability to come to mutually agreeable terms.

F-27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.” These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

Overview

Alkame Holdings, Inc. (the "Company", “we”, “us” or “our”) was incorporated under the laws of the State of Nevada on April 19, 2010. 

The Company is in the business of distributing bottled/canned alkaline, antioxidant and oxygenated water.

On June 24, 2013, the Company entered into a share exchange agreement with Alkame Water, Inc. (“Alkame”) and the shareholders of all of the issued and outstanding shares of Alkame. On June 25, 2013, the Company acquired 100% of the members’ shares of Alkame, a Company incorporated in the state of Nevada on March 1, 2012, in exchange for 150,000,000 common shares, comprised of 116,666,667 common shares privately transacted from the President of Company and the issuance of 33,333,333 common shares to shareholders of Alkame. Effectively, Alkame held 71% of the issued and outstanding common shares of the Company and the transaction has been accounted for as a reverse merger, where Alkame is deemed to be the acquirer and or the surviving entity for accounting purposes.

As part of the acquisition transaction, all assets and liabilities of Alkame Holdings, Inc. at the date of acquisition were assumed by the former management.

The transaction is accounted for using the purchase method of accounting. As a result of the recapitalization and change in control, Alkame is the acquiring entity in accordance with ASC 805, Business Combinations. Accordingly, the historical financial statements are those of Alkame, the accounting acquirer, immediately following the consummation of the reverse merger.

On January 13, 2015, the Company completed the acquisition of Xtreme Technologies, Inc., an Idaho corporation.

Under the Agreement, Amendment, and Second Amendment, Xtreme became our wholly-owned subsidiary and we acquired the patents on the proprietary process that we believe is the most technologically advanced in water treatment systems for complete hydration. We assumed the operations of Xtreme and continue its business of distributing technologically enhanced bottled water.

Upon closing of the acquisition, we discovered that Xtreme was operating at a loss for the prior year and that it required a substantial cash infusion. We have begun a program of upgrading the production line, reorganized personnel, and began an effort to increase sales of the division so that it returns to profitability as quickly as possible.

Our primary objective now is to introduce, promote, aggressively market and establish channels of distribution to sell our product to a wide range of consumers, first in the United States, Canada and Mexico, and then globally.

We believe that holding the patents will enable us to enhance our position in the investment community, allow us to expand our reach in the distribution of product, and provide us access to other applications the water treatment technology has available. We are exploring other uses of our water so that we can diversify our portfolio of products to include other specialty uses outside of the bottled water and health water markets.

4

Sales and Marketing

Our patented technology holds many new and unique possibilities for us, much more than just a bottled water company. Alkame Holdings Inc. is a holding company, and Alkame Water, High Country Shrimp, and Xtreme Technologies are part of a multi-facetted business strategy, and we are actively pursuing many exciting new fronts and applications to expand upon and provide several separate potential revenue streams for the Company.

The Company's wholly-owned subsidiaries, Alkame Water, Inc., and Xtreme Technologies Inc. market and distribute enhanced waters utilizing an exclusive patented formula and technology to create water with several unique properties which increase the available oxygen content and balance pH levels, as well as provide added benefits of enhancement with electrolytes and antioxidants, which equates into many health benefits, such as, but not limited to, improved absorbability, improved metabolic efficiency, a boosted immune system, improved cardio respiratory function, and a decrease in lactic acid for faster muscle recovery. Xtreme Technologies Inc. is pursuing the household pet industries. Alkame Water is pursuing the human consumable industries.

Our organization also has “Kids” in gallon and 4 Liter formats. Alkame Kids utilizes its patented fluoride free electrolyte enhanced oxygenated water treatment technology to create this is revolutionary new product for “Kids” hydration, which can be consumed like any other electrolyte enhanced water, mixes well with cereal, juices, and formula without clumping or the need for massive amounts of sodium, sugars, and flavors. We call it “The Best of Both Worlds”, and electrolyte enhanced water, that works like drinking water.

Aquaculture is a sector we are actively pursuing, and have formed a division to explore applications into the seafood production industries. Testing has been underway in Colorado, with promising results in working with fresh water aquatic species. We hope the formal data and results from use of our technology provides a benefit and can be implemented into fish farms globally.

Alkame Holdings Inc. and its subsidiaries continue to grow under a “Grass Roots” methodology, building a strong foundation through a slow and methodical organic approach to distribution into retail, as well as online and alternative channels.

Results of Operations for the three and nine months ended September 30, 2015 and 2014.

Operating Revenues

In the three and nine month periods ended September 30, 2015 we generated $199,320 and $800,571, respectively, in revenue, versus $6,665 and $105,676 for the three and nine month periods ended September 30, 2014, from the sales of our water products. The increase is due to two factors: (i) in the first quarter of 2014, the Company was just beginning its sales efforts, so Quarter 1 of 2015 was the first full quarterly comparison; and (ii) we have additional sales from the acquisition of Xtreme Technologies, Inc. which occurred in the first quarter of 2015 (see Footnote 11). We expect that over the coming months, our sales and marketing efforts will result in significantly increasing sales.

Cost of Goods Sold

In the three and nine month periods ended September 30, 2015, we incurred $231,596 and $691,499, respectively, as cost of goods sold versus $33,717 and $129,340 for the respective periods ended September 30, 2014. The increase is primarily due to the increase in revenue generated by Alkame Water and the addition of Xtreme Technologies in Q1 of 2015. We expect that over the coming months, our cost of goods sold will increase as a result of significantly increasing sales.

Gross profit

For the three and nine months ended September 30, 2015, our gross (loss) profit was ($32,276) (16.2% of revenue) and $109,072 (13.6% of revenue) compared to gross losses of $27,052 (405.9% of revenue) and $23,664 (22.4% of revenue) for the three and nine month periods ended September 30, 2014. The increase in gross profit dollar amount and in gross profit percentage in 2015 from 2014, is a direct result of the acquisition of Xtreme Technologies. We are able to amortize the manufacturing and management overhead of the two companies over a larger sales base, and therefore generate a better gross margin.

5

Operating Expenses

Our operating expenses for the three and nine month periods ended September 30, 2015 and 2014 are outlined in the table below:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2015		2014		2015		2015
Selling expenses	$	128,129	$	242,935	$	571,415	$	642,800
General and administrative		359,412		110,359		899,960		261,129
Depreciation and amortization		26,272		711		110,206		2,133
Impairment of goodwill		658,187		—		658,187		—
Impairment of customer list		218,750		—		218,750		—
Total	$	1,390,750	$	354,005	$	2,458,518	$	906,062

Operating expenses for the three and nine months ended September 30, 2015 was $1,390,750 and $2,458,518 respectively, versus $354,005 and $906,062 for the three and nine months ended 2014 respectively. The increase in operating expense during the three and nine months ended September 30, 2015 versus 2014 is attributed to impairment of intangibles assets of $876,397 and an increase in general and administrative costs including professional fees for legal, accounting, and audit services required for SEC filing requirements, accrued wages, impairment of intangible assets, and other general and administrative costs incurred by the acquisition of Xtreme.

Other Income/(Expenses)

In addition to operating expenses, we incurred interest expenses of $57,660 and $133,082 during the three and nine months ended September 30, 2015 respectively, versus $1,032,993 and $1,073,546 for the three and nine month periods ended September 30, 2014, respectively. The decrease in interest expense during the periods ended September 30, 2015 is primarily attributable to the incurrence of significant finance fees and “original issued discounts” on debt incurred in 2014 which was recorded at their inception with no corresponding transactions in the current year.

We incurred amortization of deferred financing cost of $11,441 and $74,810 during the three and nine months ended September 30, 2015 respectively, versus $18,549 and $34,799 for the three and nine month periods end September 30, 2014, respectively. The decrease in amortization of deferred financing cost during the period ended September 30, 2015 is primarily attributable to the completion of the amortization incurred on the various underlying debt incurred from financing activities over the last year.

Non-cash interest expense due to adjustments connected with derivative instrument adjustments related to convertible notes used to finance the Company include gains of $347,251 and $499,266 for the three and nine months ended September 30, 2015 versus gains of $374,363 and $374,363 for the three and nine month periods ended September 30, 2014, respectively as a result of the change in fair value of the Company’s derivative instruments, and amortization of debt discount of $161,324 and $628,111 for the three and nine month periods ended September 30, 2015 versus $46,845 and $46,845 for the three and nine months ended September 30, 2014 periods.

Net Loss

We incurred a net loss of $1,306,304 and $2,685,556 for the three and nine months ended September 30, 2015 respectively versus $1,105,081 and $1,710,552 for the three and nine months ended September 30, 2014, respectively.

Liquidity and Capital Resources

The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing, and generating profitable operations from the Company’s future operations. However, there can be no assurance that these arrangements will be sufficient to fund its ongoing capital expenditures, working capital, and other cash requirements. The outcome of these matters cannot be predicted at this time. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.

6

Working Capital

							Percentage
	September 30,			December 31,			Increase
	2015			2014			(Decrease)
Current Assets	$	288,172		$	585,483			(50.8	%)
Current Liabilities	$	5,440,167		$	2,643,808			105.8	%
Working Capital Deficit	$	(5,151,995	)	$	(2,058,325	)		150.3	%

At September 30, 2015, our cash balance was $749 compared to $172,730 at December 31, 2014. The decrease in cash is attributed to proceeds of $22,967 in notes payable to an officer, $353,833 from the issuance of convertible notes payable, and proceeds of $171,515 from short term cash flow loans, all of which were used to pay operating expenses, purchases of inventory, equipment upgrades, and final payment on our previously announced acquisition with the remaining amounts unspent.

At September 30, 2015, we had total current liabilities of $5,440,167 compared with total current liabilities of $2,643,808 at December 31, 2014. The increase in total liabilities is attributed to a decrease in derivative liability of $145,434 on convertible notes, an increase in Series C convertible preferred stock to be issued of $1,425,000 and accounts payable and accrued liabilities of $756,237 due to timing differences between the payment terms of various operating expenditures. We also received proceeds of $22,967 in notes payable to an officer, and $353,833 received from the issuance of convertible debt during the nine-month period, and made repayments of principal and interest of $59,791 for notes and accrued interest.

At September 30, 2015, we had a working capital deficit of $5,151,996 compared with a working capital deficit of $2,058,325 at December 31, 2014. The increase in working capital deficit is attributed to the consumption of various prepaid services paid for by the issuance of restricted stock, losses incurred in ramping up our production and inventory, the recording of Series C convertible preferred stock to be issued of $1,425,000 and an increase in accrued expenses.

Cash Flows

	For The Nine Months Ended						Percentage
	September 30,			September 30,			Increase
	2015			2014			(Decrease)
Cash Used in Operating Activities	$	(561,374	)	$	(309,881	)		(81.2	)%
Cash Used in Investing Activities	$	(87,338	)	$	(57,168	)		(52.8	)%
Cash Provided by Financing Activities	$	476,731		$	400,500			19.0	%
Net Increase (Decrease) in Cash	$	(171,981	)	$	33,451			(614.1	)%

Cash flow from Operating Activities

During the nine months ended September 30, 2015, we used $561,374 of cash in operating activities compared to the use of $309,881 of cash for operating activities during the period ended September 30, 2014. The increase in the use of cash for operating activities was mainly attributed to our net loss of $2,685,556, offset mainly by impairment of intangible assets of $876,937, depreciation and amortization of $127,021, amortization of deferred financing cost of $74,810, bad debt expense of $125,000, $110,826 for non-cash interest expense accrued on notes payable, and $253,000 for prepaid assets amortized during the period, an adjustment of amortization of debt discount of $628,111, decrease in accounts receivable – others of $24,056 and an increase of $524,871 in accounts payable and accrued expenses offset by gain on change in fair value of derivative liability of $499,266 and an increase in accounts receivable of $93,750, and an increase in inventory of $27,434.

7

Cash flow from Investing Activities

During the nine months ended September 30, 2015, we used $87,338 in investing activities. We used $43,395 for the purchase of certain upgrades to our manufacturing equipment utilized by the bottling manufacturer in producing our product, paid $45,100 to Xtreme Technologies, Inc. as part of Stock Purchase Agreement, paid $12,130 on potential joint venture offset by a cash acquired from Xtreme of $13,287.

Cash flow from Financing Activities

During the nine months ended September 30, 2015 and 2014, we received net proceeds of $476,731 and $400,500, respectively from financing activities. The increase in proceeds from financing activities is mainly attributed to $353,833 from the issuance of convertible debentures which are unsecured, bear interest at between 8% and 15% per annum, proceeds from notes payable others of $171,515 and additional loans from an officer in the amount of $22,967, less payment of financing costs and repayments for an outstanding note payable and the accrued interest thereon.

Going Concern

These accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. For the nine months ended September 30, 2015, the Company recognized $800,571 in revenue, and as of September 30, 2015 had an accumulated deficit of $11,156,906. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing, and generating profitable operations from the Company’s future operations. However, there can be no assurance that these arrangements will be sufficient to fund its ongoing capital expenditures, working capital, and other cash requirements. The outcome of these matters cannot be predicted at this time. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These accompanying unaudited condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Future Financings

We will continue to rely on equity sales of our common shares in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our operations and other activities.

Critical Accounting Policies

Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

We regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these policies is included in the notes to our financial statements. In general, management's estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.

Our significant accounting policies are more fully described in Note 4 to our unaudited condensed consolidated financial statements.

8

Recently Issued Accounting Pronouncements

Our significant accounting policies are more fully described in Note 4 to our unaudited condensed consolidated financial statements.

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

Off-Balance Sheet Arrangements

We had no off-balance sheet arrangements as of September 30, 2015 and December 31, 2014.

Inflation

We do not believe that inflation has had a material effect on our Company’s results of operations.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not Applicable.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2015. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2015, our disclosure controls and procedures were not effective due to the presence of material weaknesses in internal control over financial reporting.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that, as of September 30, 2015, our disclosure controls and procedures were not effective: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.

Remediation Plan to Address the Material Weaknesses in Internal Control over Financial Reporting

Our company plans to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending December 31, 2015: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.

We are unable to remedy our controls related to the inadequate segregation of duties and ineffective risk management until we receive financing to hire additional employees.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the nine months ended September 30, 2015 that have materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.

9

PART II-OTHER INFORMATION

Item 1. Legal Proceedings.

In April 2014, we were notified that a note holder disputes the balance of his note as recorded on the books of our company. The discrepancy arises from a question regarding expenses that the holder claims were paid on behalf of our company and subsequent payments that we recorded as payments against the note. We have no record of the expenses claimed to be due, and we are in negotiations to settle this matter. We have accrued $28,000 to cover the potential expenses and adjustments to accrued interest if the claim is substantiated. We believe it has properly accounted for all payments made to the individual and have provided documentation to him substantiating our position.

Renard Wigginsetal.v.AlkameHoldings,Inc.etal.,casenumberA-14-700799- C, Eighth Judicial District Court, Clark County,Nevada (the "Wiggins Lawsuit"). Renard Wiggins fileda Complaint on May 15, 2014, against the Company and Robert Eakle, asserting claims for breaches of contracts, tortious and contractual breachesof implied covenants of good faith and fair dealing, breaches of fiduciary duties, conversion, and unjust enrichment, and seeking damages in excess of $10,000, as wellas declaratory and injunctive relief, in connection with purported stock and royalty agreements from or before June of 2012, between the plaintiff and Alkame Water, Inc.

 After successive motions to dismiss, on February 18, 2015, the Wiggins Lawsuit was amended, with the addition of Alkaline Royalty Corp. as a co-plaintiff, and the scope of claims asserted in their Second Amended Complaint was narrowed, with the dismissal of Robert Eakle and leaving remaining claims against the Company for non-tort breaches of contract with damages in excess of $10,000 and declaratory and injunctive relief in connection with the purported stock and royalty agreements. Among other things, the plaintiffs request "declaratory judgment that it is entitled to the shares, ownership or equity in Alkame Holdings reflecting the 20% stake in Alkame Water he should have received pursuant to the Stock Agreement and/or any proceeds which would have resulted had he received those shares or equity stake in Alkame Water prior to the merger with Pinnacle ass promised and that he is entitled to his royalty payments."

The discovery period was extended to the end of December, with trial scheduled for the end of February 2016. The parties continue to be engaged in settlement discussions that may or may not prove fruitful. Absent an acceptable settlement, theCompanyintends tovigorously defend against theplaintiffs' claims. Itistoo early to evaluate withany certainty the likely outcome of the litigation initiated by the plaintiffs. In February 2016, the Company engaged new counsel and the trial originally scheduled for February 2016, is now scheduled for March 2016.

The Company may, from time to time, become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. The Company is currently not aware of any such legal proceedings that it believes will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results.

Item 1A. Risk Factors.

Not Applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On January 28, 2014, six stockholders exchanged a total of 65,210,834 common shares for 65,210,834 Series B Convertible Preferred Stock.

On January 28, 2014, six stockholders exchanged a total of 65,210,834 common shares for 65,210,834 Series B Convertible Preferred Stock.

On January 12, 2015, the Company issued 3,600,000 common shares at an average price of $0.01926 per share to an accredited investor group in settlement of $69,336 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

10

In February 2015, the Company issued 6,500,000 common shares at a price of $0.01706 per share to an accredited investor group in settlement of $110,910 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In February 2015, the Company issued 13,365,052 common shares at an average price of $0.01291 per share upon conversion by the holders of $166,970 of convertible debentures and $5,557 of accrued interest.

In March 2015, the Company issued 16,100,000 common shares at a price of $0.00426 per share to an accredited investor group in settlement of $68,508 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In March 2015, the Company issued 24,373,736 common shares at an average price of $0.0108 per share upon conversion by the holders of $138,113 of convertible debentures and $4,013 of accrued interest.

In April 2015, the Company issued 6,000,000 common shares at a price of $0.0024 per share to an accredited investor group in settlement of $14,400 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In May 2015, the Company issued 7,400,000 common shares at a price of $0.0042 per share to an accredited investor group in settlement of $29,748 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In June 2015, the Company issued 10,118,865 common shares at a price of $0.00698 per share to an accredited investor group in settlement of $70,613 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In August 2015, the Company issued 8,000,000 common shares at a price of $0.00335 per share to an accredited investor group in settlement of $26,800 of accounts and notes payable they had previously acquired from the various debt holders, and an additional 7,000,000 common shares at a price of $0.003 per share to the same accredited investor group in settlement of $21,000 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In September 2015, the Company issued 5,482,288 common shares at a price of $0.00198 per share to an accredited investor group in settlement of $10,855 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In November 2015, the Company issued 9,000,000 common shares at a price of $0.00192 per share to an accredited investor group in settlement of $17,280 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In November 2015, the Company designated a Series D Preferred Stock consisting of four million (4,000,000) shares, par value $0.001. The series is convertible into common stock of the Company at a conversion of ten (10) shares of common stock for every Series D Preferred Stock. In addition, holders of the series can vote in matters submitted for vote by the shareholders at the rate of twenty-five thousand (25,000) votes for each share held. Additional rights of the holders of the Series D Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on November 25, 2015 and as Exhibit 3.1 to Form 8-K filed on November 30, 2015.

In December 2015, the Company issued 7,500,000 common shares at a price of $0.0024 per share to an accredited investor group in settlement of $18,000 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

As of September 30, 2015 and December 31, 2014, there were 181,985,547 and 74,045,606 shares of common stock issued and outstanding, respectively.  

Series C Convertible Preferred Stock to be issued:

During the nine months ended September 30, 2015, the Company committed to issue 1,425,000 shares of Series C Preferred stock valued at $1.00 per share as part of Stock Purchase Agreement entered into with Xtreme Technologies, Inc.

11

These securities were issued pursuant to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder. The investor represented his intention to acquire the securities for investment only and not with a view towards distribution. The investor was given adequate information about us to make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock. 

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit No.	Description of Exhibit
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 *	Certification of Chief Executive Officer pursuant to Section 906 Certifications under Sarbanes-Oxley Act of 2002

* Filed herewith.

12

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ALKAME HOLDINGS, INC.

By

/s/ Robert Eakle
Robert Eakle
Chief Executive Officer, President, and Director
(Principal Executive Officer and Principal Accounting Officer)
Date:	February 11, 2016

13

EX-10.1

CERTIFICATIONS

I, Robert Eakle, certify that;

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2015 of Alkame Holdings, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 11, 2016

/s/ Robert Eakle

By: Robert Eakle

Title: Chief Executive Officer

EX-10.2

CERTIFICATIONS

I, Robert Eakle, certify that;

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2015 of Alkame Holdings, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 11, 2016

/s/ Robert Eakle

By: Robert Eakle

Title: Chief Financial Officer

EX-32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly Report of Alkame Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2015 filed with the Securities and Exchange Commission (the “Report”), I, Robert Eakle, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

By:	/s/ Robert Eakle
Name:	Robert Eakle
Title:	Principal Executive Officer, Principal Financial Officer and Director
Date:	February 11, 2016

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Feb. 09, 2016
Document And Entity Information
Entity Registrant Name	Alkame Holdings, Inc.
Entity Central Index Key	0001522165
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	No
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		198,485,547
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2015

XML

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash	$ 749	$ 172,730
Accounts receivable (net of reserve for bad debts of $148,000 and $23,000, respectively)	106,558	82,510
Accounts receivable other	1,008	70,243
Prepaid expenses - current	7,000	260,000
Inventory	172,857	70,243
Total current assets	288,172	585,483
Fixed and intangible assets:
Manufacturing equipment, net	129,161	11,149
Software	13,496	17,995
Intangible assets, net	1,080,051	4,509
Total fixed and intangible assets, net	1,222,709	33,653
Other assets:
Deferred finance costs	11,898	63,375
Investments	25,630	68,400
Total other assets	37,528	131,775
Total assets	1,548,409	750,911
Current liabilities:
Accounts payable and accrued expenses	698,961	544,530
Accrued interest	237,852	146,046
Accrued compensation	510,000	762,000
Loans from officer	26,456	3,489
Notes payable	990,005	762,000
Note due Xtreme Shareholders	207,000	1,018,782
Convertible debentures (net of debt discount of $64,455 and $280,288, respectively)	471,546	168,961
Derivative instrument liability	873,348	$ 1,018,782
Series C Convertible Preferred Stock to be issued	1,425,000
Total current liabilities	5,440,167	$ 2,643,808
Long-term liabilities:
Notes payable - long term	26,199	131,490
Convertible debt - long term (net of debt discount of $73,811 and $132,254), respectively	53,412	22,968
Total long-term liabilities	79,611	154,458
Total liabilities	5,519,778	2,798,266
Commitment and contingencies		12,000
Stockholders deficit
Preferred stock - $0.001 par value, authorized - 20,000,000 shares;	12,000	12,000
Series A Convertible Preferred stock - $0.001 par value, 12,000,000 shares designated; issued and outstanding - 12,000,000 and 12,000,000 shares, respectively	12,000	12,000
Series B Preferred stock - $0.001 par value, 70,000,000 shares designated; issued and outstanding 65,398,334 and 65,398,334 shares, respectively	65,398	65,398
Common stock - $0.001 par value, authorized - 900,000,000 shares; issued and outstanding - 181,985,547 and 74,045,606 shares, respectively	181,986	74,046
Common stock to be issued	13,500	13,500
Additional paid-in capital	6,912,652	6,259,050
Accumulated deficit	(11,156,906)	(8,471,350)
Total stockholders deficit	(3,971,370)	(2,047,355)
Total liabilities and stockholders deficit	$ 1,548,409	$ 750,911

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ .001	$ 0.001
Common Stock, Shares Authorized	900,000,000	900,000,000
Common Stock, Issued and outstanding	181,985,547	74,045,606
Preferred Stock, Par Value	$ .001	$ 0.001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Series A, Par Value	$ .001	$ 0.001
Preferred Stock, Series A, Designated	12,000,000	12,000,000
Preferred Stock, Series A, Issued and Outstanding	12,000,000
Preferred Stock, Series B, Par Value	$ .001	$ 0.001
Preferred Stock, Series B, Designated	70,000,000	70,000,000
Preferred Stock, Series B, Issued and Outstanding	65,398,334
Bad debt reserve	$ 148,000	$ 23,000
Convertible debentures, debt discount, current	64,455	280,288
Convertible debentures, debt discount, noncurrent	$ 73,811	$ 132,254

XML

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement [Abstract]
Revenues	$ 199,320	$ 6,665	$ 800,571	$ 105,676
Cost of goods sold	231,596	33,717	691,499	129,340
Gross profit (loss)	(32,276)	(27,052)	109,072	(23,664)
Operating expenses:
Selling expenses	128,129	242,935	571,415	642,800
General and administrative	359,412	110,359	899,960	261,129
Depreciation and amortization	26,272	$ 711	110,206	$ 2,133
Impairment of goodwill	658,187		658,187
Impairment of customer list	218,750		218,750
Total operating expenses	1,390,750	$ 354,005	2,458,518	$ 906,062
Loss from operations	(1,423,026)	(381,057)	(2,349,446)	(929,726)
Other Income / (Expenses):
Amortization of deferred financing costs	(11,441)	(18,549)	(74,810)	(34,799)
Interest expense	57,660	1,032,993	133,082	1,073,546
Amortization of beneficial conversion feature	(161,324)	(46,845)	(628,111)	(46,845)
Gain on change in fair value of derivative liability	347,251	$ 374,363	499,266	$ 374,363
(Loss) gain on settlement of debt	(104)		627
Total other income (expenses)	116,722	$ 724,024	336,109	$ 780,826
Net loss applicable to common stock holders	$ (1,306,304)	$ (1,105,081)	$ (2,685,556)	$ (1,710,552)
Per share data
Net Loss per share - basic and diluted	$ (0.01)	$ (0.02)	$ (0.02)	$ (0.02)
Weighted average number of shares outstanding- basic and diluted	169,231,116	70,558,287	137,263,440	76,557,282

XML

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (2,685,556)	$ (1,710,552)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debts	125,000	3,000
Depreciation and amortization	127,021	$ 2,401
Impairment of intangible assets	876,937
Amortization of beneficial conversion feature	628,111	$ 46,845
Gain on change in fair value of derivative liability	(499,266)	(374,363)
Amortization of prepaid assets	253,000	472,000
Amortization of deferred financing costs	$ 74,810	34,799
Non-cash interest expense		1,001,280
Changes in operating asset and liability account balances:
Accounts receivable	$ 93,750	$ 69,801
Accounts receivable - others	$ 24,056
Deposits		$ 15,032
Inventory	$ (27,434)	(14,064)
Prepaid expenses		(10,000)
Accrued interest	$ 110,826	64,769
Accounts payable and accrued expenses	524,871	228,773
Total adjustments	2,124,182	1,400,671
Net cash used in operating activities	(561,374)	(309,881)
Cash flows from investing activities
Payment of purchase consideration to Xtreme Technologies, Inc.	(45,100)	$ (50,000)
Cash acquired from Xtreme Technologies, Inc.	13,287
Funds spent on potential Joint Venture	(12,130)
Purchase of equipment	43,395	$ 7,168
Net cash used in investing activities	(87,338)	$ (57,168)
Cash flows from financing activities:
Proceeds from officer loans	22,967
Payment of financing costs	(26,893)	$ (39,250)
Proceeds from notes payable	171,515	100,000
Payments of notes payable	(44,691)	(7,000)
Proceeds from convertible notes	353,833	346,750
Net cash provided by financing activities	476,731	400,500
Net decrease in cash	(171,981)	33,451
Cash at beginning of period	172,730	128,258
Cash at end of period	749	$ 161,709
Supplemental Schedule of Cash Flow Information:
Cash paid for interest	$ 15,100
Cash paid for income taxes
Supplemental Schedules of Noncash Investing and Financing Activities:
Conversion of notes payable and accrued interest into common stock	314,653
Common stock issued to settle accounts payable	$ 446,889
Payment made by EROP to noteholders on Company's behalf	318,000
Assets taken over and liabilities assumed from Xtreme Technologies, Inc.	$ 2,050,000
Conversion of common shares in Series B convertible preferred stock		$ 65,211
Beneficial conversion feature on convertible debt	$ 353,832	1,348,030
Common stock issued for deferred financing cost		625,000
Amortization of equity deferred financing cost to additional paid-in capital		$ 26,042

XML

Organization and Nature of Operations

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Nature of Operations

Alkame Holdings, Inc. (the "Company", “we”, “us” or “our”) was incorporated under the laws of the State of Nevada on April 19, 2010. 

The Company is in the business of distributing bottled/canned alkaline, antioxidant and oxygenated water.

On June 24, 2013, the Company entered into a share exchange agreement with Alkame Water, Inc. (“Alkame”) and the shareholders of all of the issued and outstanding shares of Alkame. On June 25, 2013, the Company acquired 100% of the members’ shares of Alkame, a Company incorporated in the state of Nevada on March 1, 2012, in exchange for 150,000,000 common shares, comprised of 116,666,667 common shares privately transacted from the President of Company and the issuance of 33,333,333 common shares to shareholders of Alkame. Effectively, Alkame held 71% of the issued and outstanding common shares of the Company and the transaction has been accounted for as a reverse merger, where Alkame is deemed to be the acquirer and or the surviving entity for accounting purposes.

As part of the acquisition transaction, all assets and liabilities of Alkame Holdings, Inc. at the date of acquisition were assumed by the former management.

The transaction is accounted for using the purchase method of accounting. As a result of the recapitalization and change in control, Alkame is the acquiring entity in accordance with ASC 805, Business Combinations. Accordingly, the historical financial statements are those of Alkame, the accounting acquirer, immediately following the consummation of the reverse merger.

Stock Purchase Definitive Agreement with Xtreme Technologies, Inc.

On April 21, 2014, the Company entered into a Stock Purchase Definitive Agreement with Xtreme Technologies, Inc., an Idaho corporation. In accordance with the terms of the Agreement, the Company will purchase all of the outstanding shares of Xtreme for the purchase price of $2,050,000.00, payable as follows:

· An initial cash deposit of $50,000 was converted into a non-refundable payment to extend the closing date;

· An additional $50,000 deposit payment was made at the date of extension;

· An additional cash payment of $525,000 shall be paid on or before the Closing Date (defined below), which, along with the additional $50,000 deposit, shall pay specific obligations on Xtreme’s balance sheet;

· As amended per agreement on December 9, 2015, the balance of $1,425,000.00 shall be payable by the issuance of shares of the Company’s Series C Preferred Stock with a stated value of $1.00 per share to be divided pro rata among the Company’s shareholders of record as of the Closing Date. The Series C Preferred Stock includes an option to convert such shares of Series C Preferred Stock into the Company’s Common Stock at the market price on the day prior to conversion; and

· One of Xtreme’s previous officers and directors holds outstanding options to purchase up to 1,009,000 shares of Xtreme’s common stock at the price of $0.10 per share. At the Closing Date, pursuant to Idaho law, Xtreme shall notify this previous officer and director of his 30-day right to exercise any or all of his remaining options. If he elects to exercise any of his options within such 30-day period, the Company agrees to issue additional shares of Series C Preferred Stock in exchange for such Xtreme shares.

o After proper notice, the holder permitted the options to expire unexercised.

The following amendments were entered in relation the Xtreme acquisition:

1. Effective January 16, 2015, the sellers of Xtreme were given the option to rescind and terminate the transaction if the debt was not paid within 120 days of the closing date.

2. Effective April 15, 2015, the 120-day deadline was extended to 240 days after the closing date. Such deadline will be automatically extended by additional 30 day increments, provided that payments from EROP have been made to escrow within 60 days of the 240-day expiration period.

3. Effective December 9, 2015, the securities deliverable to the sellers of Xtreme was amended from Series B Preferred Stock to Series C Preferred Stock.

On January 13, 2015, the Company completed the acquisition of Xtreme Technologies, Inc., an Idaho corporation.

Under the Agreement, Amendment, and Second Amendment, Xtreme became our wholly-owned subsidiary and we acquired the patents on the proprietary process that we believe is the most technologically advanced in water treatment systems for complete hydration. We assumed the operations of Xtreme and continue its business of distributing technologically enhanced bottled water.

Upon closing of the acquisition, we discovered that Xtreme was operating at a loss for the prior year and that it required a substantial cash infusion. We have begun a program of upgrading the production line, reorganized personnel, and began an effort to increase sales of the division so that it returns to profitability as quickly as possible.

Our primary objective now is to introduce, promote, aggressively market and establish channels of distribution to sell our product to a wide range of consumers, first in the United States, Canada and Mexico, and then globally.

We believe that holding the patents will enable us to enhance our position in the investment community, allow us to expand our reach in the distribution of product, and provide us access to other applications the water treatment technology has available. We are exploring other uses of our water so that we can diversify our portfolio of products to include other specialty uses outside of the bottled water and health water markets.

The Company’s fiscal year end is December 31.

XML

Going Concern

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

These accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. For the nine months ended September 30, 2015, the Company recognized $800,571 in revenue, and as of September 30, 2015 had an accumulated deficit of $11,156,906. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing, and generating profitable operations from the Company’s future operations. However, there can be no assurance that these arrangements will be sufficient to fund its ongoing capital expenditures, working capital, and other cash requirements. The outcome of these matters cannot be predicted at this time. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These accompanying unaudited condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Basis of Presentation

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

a)   Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

b) Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries Alkame Water, Inc. and Xtreme Technologies, Inc. All significant inter-company transactions are eliminated.

c)   Cash and Cash Equivalents

For purposes of the statement of cash flows, cash includes demand deposits, saving accounts and money market accounts. The Company considers all highly liquid instruments with maturities of three months or less when purchased to be cash equivalents.

d) Accounts receivable and concentration of credit risk

Because the Company currently uses distributors as their main source of product sales and placement, there is an inherent risk that the distributor could experience difficulty in their payments for accounts they ship to. The result, may be that they, while collecting from the stores and chains they supply, they do not process through the payments to us. Although in the past the Company did see significant credit risk associated with the trade receivables, repayment is dependent upon the financial stability of the various distributors and customers to which shipment takes place. As a result, the Company is looking more closely at the credit worthiness of its customer and how large a footprint and customer base various distributors have, and is attempting to limit how much of our business is conducted through any one customer or distributor. Our concentration risk is being reevaluated on a quarterly basis.

e) Allowance for doubtful accounts

The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts and the aging of the accounts receivable.  The Company regularly reviews the adequacy of the Company’s allowance for doubtful accounts through identification of specific receivables where it is expected that payments will not be received.  The Company also establishes an unallocated reserve that is applied to all amounts that are not specifically identified.  In determining specific receivables where collections may not have been received, the Company reviews past due receivables and gives consideration to prior collection history and changes in the customer’s overall business condition.  The allowance for doubtful accounts reflects the Company’s best estimate as of the reporting dates.

At September 30, 2015 and December 31, 2014, the Company had an allowance for bad debts in the amount of $148,000 and $23,000 respectively.

f) Basic and Diluted Net Loss per Share

The Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS

is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. Such securities, shown below, presented on a common share equivalent basis and outstanding as of September 30, 2015 and 2014 have been excluded from the per share computations:

	As of
	September 30, 2015		September 30, 2014
Series A Convertible Preferred Stock		600,000,000		600,000,000
Series B Convertible Preferred Stock		65,398,334		65,210,834
Series C Convertible Preferred Stock		356,250,000		—
Convertible notes payable		356,576,614		5,862,185
Warrants		1,587,302		—
EROP conversion of debt		136,543,519		—

g) Financial Instruments

Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2015, with the exception of its convertible notes payable. The carrying amounts of these liabilities at September 30, 2015 approximate their respective fair value based on the Company’s incremental borrowing rate.

Cash is considered to be highly liquid and easily tradable as of September 30, 2015 and therefore classified as Level 1 within our fair value hierarchy.

In addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments

h) Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

Professional standards generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.  Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt Instrument”.

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

i) Derivative Liabilities

The Company assessed the classification of its derivative financial instruments as of March 31, 2015, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

j) Income Taxes

Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740 “Accounting for Income Taxes” as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in this financial statement because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.

k) Revenue Recognition

The Company recognizes revenue in accordance with ASC-605, “Revenue Recognition,” which requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or title has passed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts.

Revenues are recognized upon shipment, provided that a signed purchase order has been received, the price is fixed, title has transferred, collection of resulting receivables is reasonably assured, and there are no remaining significant obligations. Reserves for sales returns and allowances, including allowances for so called “ship and debit” transactions, are recorded at the time of shipment, based on historical levels of returns and discounts, current economic trends and changes in customer demand. Certain Internet generated transactions that are prepaid at time of order, are recognized at the time the merchandise ships from the warehouse to the customer.

Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

l) Reclassification

Certain reclassifications have been made to conform the prior period data to the current presentation. These reclassifications had no effect on reported net loss.

XML

Notes Payable

9 Months Ended

Sep. 30, 2015

Notes Payable [Abstract]

Notes Payable

Notes Payable to Stockholders:

The Company owed $38,199 and $43,490 at September 30, 2015 and December 31, 2014 respectively to a stockholder. 

During the year ended December 31, 2013, the Company had $63,000 in expenses paid on its behalf by this shareholder which was recorded as a Note. On August 1, 2013, the Company and note holder amended the Note by mutual agreement increasing the principal amount by an additional $10,000 for other services rendered by the former director.  The Note is unsecured, and begin accruing interest August 1, 2014 at 5% per annum on the unpaid principal thereafter.  Based on a repayment agreement that calls for monthly payments of $1,000 per month.

During the nine months ended September 30, 2015 and 2014, the Company repaid $8,000 ($5,291 principal and $2,709 accrued interest) and $7,000 of the Note, respectively.  

Notes Payable to Xtreme Shareholders:

In January 2015, an accredited investor group, EROP, filed and received approval by the courts for a 3(a)10 filing under which they acquired various debts, including the note due to the former shareholders of Xtreme Technologies, Inc. Under terms of the court order, they are able to convert the debts into common shares of the Company at a 40% discount to the market.

The original balance acquire was $525,000. As of September 30, 2015 the balance is $207,000.

Notes Payable, others:

On March 29, 2013, the Company entered into a two-year promissory note agreement for $500,000. On April 8, 2013, the Company received $200,000 and on May 1, 2013, the Company received $300,000. On September 27, 2013, the note agreement was amended to include an additional advance to the Company of $250,000.  Pursuant to the agreement, the loan is secured with a general security agreement, bears interest at 10% per annum, and $500,000 is due on March 30, 2015 and $250,000 is due on September 27, 2015. These notes are currently in technical default. To date, the lender has not declared a default, and continues to forebear on collection.

On March 11, 2014, the Company entered into an additional two-year promissory note agreement for an additional $100,000 from the same investor group, on the same terms as outlined above.

At September 30, 2015 and December 31, 2014, the Company has accrued interest of $183,625 and $119,875, respectively. The original note, and the amendment, each mature two years from date of issuance or amendment.

At September 30, 2015, the Company classified $850,000 of this note payable as current liability.

The Company paid 10% of proceeds from $750,000 of the long-term notes payable as financing cost of $75,000 to a consultant. The Company will amortize this cost over the term of the long-term note payable.

The Company paid 10% of proceeds from the $100,000 long-term notes payable as financing cost of $10,000 to a consultant. The Company will amortize this cost over the term of the long-term note payable.

During the nine months ended September 30, 2015 and 2014, the Company charged to operations $74,810 and $34,799 as amortization of deferred financing costs, respectively. As of September 30, 2015 and December 31, 2014, remaining balance in deferred financing cost of $11,898 and $63,375, respectively and is presented as part of other assets.

In July 2015, the Company borrowed $70,000 from an accredited investor group on a term loan. The note carries interest at 15% per annum and requires repayment of a total of $98,000 through daily payments of $560.

In July 2015, the Company borrowed $25,000 from an accredited investor group on a term loan. The note carries prepaid interest of 10% of the amount borrowing.

In August 2015, the Company borrowed $50,000 from an accredited investor group on a term loan. The note carries interest at 15% per annum and requires repayment of a total of $74,500 through daily payments of $899.

XML

Convertible debt

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Convertible debt

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

Professional standards generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.  Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt Instrument”.

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value: 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement.  

Items recorded or measured at fair value on a recurring basis in the accompanying unaudited condensed consolidated financial statements consisted of the following items as of September 30, 2015:

			Fair Value Measurements at  September 30, 2015 using:
	September 30, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Derivative Liabilities	$	873,348		—		—	$	873,348

The debt derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors based on historical prices for the Company’s common stock and are classified within Level 3 of the valuation hierarchy. 

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of September 30, 2015:

		Derivative Liability
Balance, December 31, 2014	$	1,018,782
Additions		668,537
Change in fair value of derivative liabilities		(813,971	)
Balance, September 30, 2015	$	873,348

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2015

Related Party Transactions [Abstract]

Related Party Transactions

During the nine months ended September 30, 2015 and 2014, the Company received $22,967 and $0, respectively, in cash loans, and made cash payments on these amounts owing totaling $0 and $0 during the same periods. 

As of September 30, 2015 and December 31, 2014, the Company owed $26,456 and $3,489, to its President. The amounts owing are unsecured, non-interest bearing and due on demand.

As of September 30, 2015 and December 31, 2014, the Company owes $210,000 and $120,000, respectively to Kaufman & Associates (holding more than 5% shares of the Company) in connection with a consulting agreement.

XML

Stockholders Deficit

9 Months Ended

Sep. 30, 2015

Equity [Abstract]

Stockholders Deficit

Where applicable, all common share numbers have been restated to retroactively reflect, the 1:3 reverse split affected by the Company on January 8, 2014.

a) Authorized

Authorized capital stock consists of:

· 900,000,000 common shares with a par value of $0.001 per share; and

· 100,000,000 preferred shares with a par value of $0.001 per share;

o The Company has designated 12,000,000 shares as Series A Convertible Preferred Series Stock. Each share of Series A Preferred Stock is convertible into fifty (50) shares of Common Stock.

o The Company has designated 70,000,000 shares as Series B Convertible Preferred Series Stock. Each share of Series B Preferred Stock is convertible into one (1) share of Common Stock.

o The Company has designated 10,000,000 shares as Series C Convertible Preferred Series Stock. Each share of Series C Preferred Stock is convertible into $1.00 of Common Shares at the market price on the date of conversion.

Increase in authorized shares

On January 24, 2014, the Company filed a Certificate of Amendment to the Company’s Articles of Incorporation (the “Certificate of Amendment”) with the Nevada Secretary of State. The Certificate of Amendment amends Article III of the Company’s Articles of Incorporation to authorize the issuance of up to one hundred million (100,000,000) shares of Preferred Stock, par value $0.001 per share, which may be issued in one or more series, with such rights, preferences, privileges and restrictions as shall be fixed by the Company’s Board of Directors from time to time. As a result of the Certificate of Amendment, we now have one billion (1,000,000,000) authorized shares, par value $0.001 per share, consisting of two classes designated as “Common Stock” and “Preferred Stock.” The total number of shares of Common Stock that we have authority to issue is nine hundred million (900,000,000) shares and the total number of shares of Preferred Stock that we have authority to issue is one hundred million (100,000,000) shares. The Company’s Board of Directors and a majority of our shareholders approved the Certificate of Amendment.

Series B Convertible Preferred Stock

On January 24, 2014, pursuant to Article III of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock entitled Series B Preferred Stock, consisting of up to seventy million (70,000,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series B Preferred Stock will participate on an equal basis per-share with holders of our common stock and Series A Preferred Stock in any distribution upon winding up, dissolution, or liquidation. Holders of Series B Preferred Stock are entitled to convert each share of Series B Preferred Stock into one (1) share of common stock. Holders of Series B Preferred Stock are also entitled to vote together with the holders of our common stock and Series A Preferred Stock on all matters submitted to shareholders at a rate of one (1) vote for each share held.

The rights of the holders of Series B Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on January 24, 2014.

Series C Convertible Preferred Stock

On January 24, 2014, pursuant to Article III of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock entitled Series C Preferred Stock, consisting of up to ten million (10,000,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series C Preferred Stock will be entitled to receive the Stated Value per share ($1.00) in any distribution upon winding up, dissolution, or liquidation. Holders of Series C Preferred Stock are entitled to convert such number of shares of Common Stock equal to the quotient of the Stated Value per share divided by the closing price of our common stock on the day of conversion. Holders of Series C Preferred Stock are also entitled to vote together with the holders of our common stock, Series A Preferred Stock and Series B Preferred Stock on all matters submitted to shareholders at a rate of one (1) vote for each share held.

The rights of the holders of Series C Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on January 24, 2014.

b) Share Issuances

On January 28, 2014, six stockholders exchanged a total of 65,210,834 common shares for 65,210,834 Series B Convertible Preferred Stock.

On January 12, 2015, the Company issued 3,600,000 common shares at an average price of $0.01926 per share to an accredited investor group in settlement of $69,336 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In February 2015, the Company issued 6,500,000 common shares at a price of $0.01706 per share to an accredited investor group in settlement of $110,910 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In February 2015, the Company issued 13,365,052 common shares at an average price of $0.01291 per share upon conversion by the holders of $166,970 of convertible debentures and $5,557 of accrued interest.

In March 2015, the Company issued 16,100,000 common shares at a price of $0.00426 per share to an accredited investor group in settlement of $68,508 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In March 2015, the Company issued 24,373,736 common shares at an average price of $0.0108 per share upon conversion by the holders of $138,113 of convertible debentures and $4,013 of accrued interest.

In April 2015, the Company issued 6,000,000 common shares at a price of $0.0024 per share to an accredited investor group in settlement of $14,400 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In May 2015, the Company issued 7,400,000 common shares at a price of $0.0042 per share to an accredited investor group in settlement of $29,748 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In June 2015, the Company issued 10,118,865 common shares at a price of $0.00698 per share to an accredited investor group in settlement of $70,613 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In August 2015, the Company issued 8,000,000 common shares at a price of $0.00335 per share to an accredited investor group in settlement of $26,800 of accounts and notes payable they had previously acquired from the various debt holders, and an additional 7,000,000 common shares at a price of $0.003 per share to the same accredited investor group in settlement of $21,000 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In September 2015, the Company issued 5,482,288 common shares at a price of $0.00198 per share to an accredited investor group in settlement of $10,855 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

As of September 30, 2015 and December 31, 2014, there were 181,985,547 and 74,045,606 shares of common stock issued and outstanding, respectively.  

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

On January 13, 2015, the Company purchased one hundred percent (100%) of the shares of Xtreme Technologies, Inc. The aggregate purchase price was $2,050,000, paid as follows: (i) cash of $100,000; (ii) 1,425,000 restricted Preferred Series C stock shares valued at $1.00 per share, totaling $1,425,000; (iii) an unsecured promissory note of $525,000. This transaction was accounted for under the purchase method in accordance with ASC 805.

In connection with the Xtreme Technologies, Inc. acquisition, the Company identified and recognized intangible assets of $1,400,000 representing patents, trade names, and customer relationships. The assets were being amortized on a straight line basis over their estimated life of seven (7) years for the patents, and three (3) years for the trade names and customer relationships. This resulted in the sum of the future net cash flows discounted to its present day value. The valuation provided for the patents, trade name, and customer relationships was based on management’s calculations. During the nine months ended September 30, 2015 and 2014, the Company recognized amortization expense of $103,571 and $0, respectively. The Company will recognize amortization expense of $24,107 in the remainder of fiscal year ending 2015, $192,857 in the fiscal year ending 2016, $192,857 in the fiscal year ending 2017, $167,857 in the fiscal year ending 2018, and $142,857 each year in the fiscal years 2019 through 2024 and $71,429 in the fiscal year ending 2025. At September 30, 2015, the Intangible asset balance, net of accumulated amortization and impairment, is $1,077,679.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:

ASSETS:
Current assets	$	144,112
Property & equipment		91,431
Intangible assets		1,400,000
Goodwill		658,187
Total	$	2,293,730
LIABILITIES:
Current liabilities	$	243,730
Net purchase price	$	2,050,000

In the third quarter of 2015, the Company determined that the goodwill and the balance of the unamortized customer list should be written down to zero value. As a result, the Company recorded a total impairment to the intangible assets of $876,937.

Purchase Price Allocation

In accordance with ASC 805, Business Combinations, the Company recorded the assets acquired and liabilities assumed at their respective estimated fair values as of the acquisition date. The total estimated purchase prices were allocated to the assets acquired and liabilities assumed based on their estimated fair values. The fair value allocation is preliminary and is subject to change based on evaluations of the assets to be performed by the Company.

The following unaudited pro forma consolidated results of operations have been prepared, as if the acquisition had occurred as of January 1, 2014: 

	Nine months ended September 30,
	2015			2014
	(Unaudited)			(Unaudited)
Revenue	$	804,676		$	989,844
Net loss from continuing operations	$	(1,792,303	)	$	(1,658,811	)
Net loss per share from continuing operations	$	(0.01	)	$	(0.02	)
Weighted average number of common stock shares – Basic and diluted		181,985,547			74,045,606

Series C Convertible Preferred Stock to be issued:

During the nine months ended September 30, 2015, the Company committed to issue 1,425,000 shares of Series C Preferred stock valued at $1.00 per share as part of Stock Purchase Agreement entered into with Xtreme Technologies, Inc.

XML

Acquisition of Xtreme Technologies, Inc.

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Acquisition of Xtreme Technologies, Inc.

On January 13, 2015, the Company purchased one hundred percent (100%) of the shares of Xtreme Technologies, Inc. The aggregate purchase price was $2,050,000, paid as follows: (i) cash of $100,000; (ii) 1,425,000 restricted Preferred Series C stock shares valued at $1.00 per share, totaling $1,425,000; (iii) an unsecured promissory note of $525,000. This transaction was accounted for under the purchase method in accordance with ASC 805.

In connection with the Xtreme Technologies, Inc. acquisition, the Company identified and recognized intangible assets of $1,400,000 representing patents, trade names, and customer relationships. The assets were being amortized on a straight line basis over their estimated life of seven (7) years for the patents, and three (3) years for the trade names and customer relationships. This resulted in the sum of the future net cash flows discounted to its present day value. The valuation provided for the patents, trade name, and customer relationships was based on management’s calculations. During the nine months ended September 30, 2015 and 2014, the Company recognized amortization expense of $103,571 and $0, respectively. The Company will recognize amortization expense of $24,107 in the remainder of fiscal year ending 2015, $192,857 in the fiscal year ending 2016, $192,857 in the fiscal year ending 2017, $167,857 in the fiscal year ending 2018, and $142,857 each year in the fiscal years 2019 through 2024 and $71,429 in the fiscal year ending 2025. At September 30, 2015, the Intangible asset balance, net of accumulated amortization and impairment, is $1,077,679.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:

ASSETS:
Current assets	$	144,112
Property & equipment		91,431
Intangible assets		1,400,000
Goodwill		658,187
Total	$	2,293,730
LIABILITIES:
Current liabilities	$	243,730
Net purchase price	$	2,050,000

In the third quarter of 2015, the Company determined that the goodwill and the balance of the unamortized customer list should be written down to zero value. As a result, the Company recorded a total impairment to the intangible assets of $876,937.

Purchase Price Allocation

In accordance with ASC 805, Business Combinations, the Company recorded the assets acquired and liabilities assumed at their respective estimated fair values as of the acquisition date. The total estimated purchase prices were allocated to the assets acquired and liabilities assumed based on their estimated fair values. The fair value allocation is preliminary and is subject to change based on evaluations of the assets to be performed by the Company.

The following unaudited pro forma consolidated results of operations have been prepared, as if the acquisition had occurred as of January 1, 2014: 

	Nine months ended September 30,
	2015			2014
	(Unaudited)			(Unaudited)
Revenue	$	804,676		$	989,844
Net loss from continuing operations	$	(1,792,303	)	$	(1,658,811	)
Net loss per share from continuing operations	$	(0.01	)	$	(0.02	)
Weighted average number of common stock shares – Basic and diluted		181,985,547			74,045,606

Series C Convertible Preferred Stock to be issued:

During the nine months ended September 30, 2015, the Company committed to issue 1,425,000 shares of Series C Preferred stock valued at $1.00 per share as part of Stock Purchase Agreement entered into with Xtreme Technologies, Inc.

XML

Subsequent Events

9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

Subsequent Events

We have evaluated subsequent events through the date of issuance of the unaudited condensed consolidated financial statements, and did not have any material recognizable subsequent events, other than the following:

In November 2015, the Company issued 9,000,000 common shares at a price of $0.00192 per share to an accredited investor group in settlement of $17,280 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

In November 2015, the Company designated a Series D Preferred Stock consisting of four million (4,000,000) shares, par value $0.001. The series is convertible into common stock of the Company at a conversion of ten (10) shares of common stock for every Series D Preferred Stock. In addition, holders of the series can vote in matters submitted for vote by the shareholders at the rate of twenty-five thousand (25,000) votes for each share held. Additional rights of the holders of the Series D Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on November 25, 2015 and as Exhibit 3.1 to Form 8-K filed on November 30, 2015.

In November 2015, the Company, retroactively entered into an employment agreement with Robert Eakle our executive officer and director for the year ended December 31, 2015. Simultaneously, the Company retroactively entered into a consulting agreement with Kaufman & Associates, Inc. Under the terms of the agreements, each will receive annual compensation of $120,000 and receive 1,000,000 shares of our newly created Series D Preferred Stock. Additional information and details of the agreements can be found in the agreements filed as Exhibits 10.1 and 10.2 to Form 8-K filed on November 30, 2015.

In December 2015, the Company issued 7,500,000 common shares at a price of $0.0024 per share to an accredited investor group in settlement of $18,000 of accounts and notes payable they had previously acquired from the various debt holders, and are being converting under a court approved settlement of a 3(a)10 filing.

As previously reported, on January 22, 2015, the Company entered into a binding Memorandum of Understanding to form a joint venture (the “MOU”) with Read Made, Inc. The purpose of the joint venture is to develop intellectual property associated with single use disposable baby bottles and market the completed products in the US and international markets.

It has been brought to the Company’s attention that Ready Made has signed a new agreement, without any formal termination of the existing MOU. The Company has decided to announce its formal rescission from the MOU, due to the inability to come to mutually agreeable terms.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company's estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Principles of Consolidation

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company's estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Cash and Cash Equivalents

For purposes of the statement of cash flows, cash includes demand deposits, saving accounts and money market accounts. The Company considers all highly liquid instruments with maturities of three months or less when purchased to be cash equivalents.

Accounts receivable and concentration of credit risk

Because the Company currently uses distributors as their main source of product sales and placement, there is an inherent risk that the distributor could experience difficulty in their payments for accounts they ship to. The result, may be that they, while collecting from the stores and chains they supply, they do not process through the payments to us. Although in the past the Company did see significant credit risk associated with the trade receivables, repayment is dependent upon the financial stability of the various distributors and customers to which shipment takes place. As a result, the Company is looking more closely at the credit worthiness of its customer and how large a footprint and customer base various distributors have, and is attempting to limit how much of our business is conducted through any one customer or distributor. Our concentration risk is being reevaluated on a quarterly basis.

Allowance for doubtful accounts

The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts and the aging of the accounts receivable.  The Company regularly reviews the adequacy of the Company’s allowance for doubtful accounts through identification of specific receivables where it is expected that payments will not be received.  The Company also establishes an unallocated reserve that is applied to all amounts that are not specifically identified.  In determining specific receivables where collections may not have been received, the Company reviews past due receivables and gives consideration to prior collection history and changes in the customer’s overall business condition.  The allowance for doubtful accounts reflects the Company’s best estimate as of the reporting dates.

At September 30, 2015 and December 31, 2014, the Company had an allowance for bad debts in the amount of $148,000 and $23,000 respectively.

Basic and Diluted Net Loss per Share

The Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS

is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. Such securities, shown below, presented on a common share equivalent basis and outstanding as of September 30, 2015 and 2014 have been excluded from the per share computations:

	As of
	September 30, 2015		September 30, 2014
Series A Convertible Preferred Stock		600,000,000		600,000,000
Series B Convertible Preferred Stock		65,398,334		65,210,834
Series C Convertible Preferred Stock		356,250,000		—
Convertible notes payable		356,576,614		5,862,185
Warrants		1,587,302		—
EROP conversion of debt		136,543,519		—

Financial Instruments

Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company did not have any Level 2 or Level 3 assets or liabilities as of September 30, 2015, with the exception of its convertible notes payable. The carrying amounts of these liabilities at September 30, 2015 approximate their respective fair value based on the Company’s incremental borrowing rate.

Cash is considered to be highly liquid and easily tradable as of September 30, 2015 and therefore classified as Level 1 within our fair value hierarchy.

In addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

Professional standards generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.  Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt Instrument”.

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

Derivative Liabilities

The Company assessed the classification of its derivative financial instruments as of March 31, 2015, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

Income Taxes

Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740 “Accounting for Income Taxes” as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in this financial statement because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.

Revenue Recognition

The Company recognizes revenue in accordance with ASC-605, “Revenue Recognition,” which requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or title has passed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts.

Revenues are recognized upon shipment, provided that a signed purchase order has been received, the price is fixed, title has transferred, collection of resulting receivables is reasonably assured, and there are no remaining significant obligations. Reserves for sales returns and allowances, including allowances for so called “ship and debit” transactions, are recorded at the time of shipment, based on historical levels of returns and discounts, current economic trends and changes in customer demand. Certain Internet generated transactions that are prepaid at time of order, are recognized at the time the merchandise ships from the warehouse to the customer.

Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.

Reclassification

Certain reclassifications have been made to conform the prior period data to the current presentation. These reclassifications had no effect on reported net loss.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Schedule of Anti-Dilutive Series A Convertible Preferred Stock

	As of
	September 30, 2015		September 30, 2014
Series A Convertible Preferred Stock		600,000,000		600,000,000
Series B Convertible Preferred Stock		65,398,334		65,210,834
Series C Convertible Preferred Stock		356,250,000		—
Convertible notes payable		356,576,614		5,862,185
Warrants		1,587,302		—
EROP conversion of debt		136,543,519		—

XML

Convertible debt (Tables)

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Convertible Notes and Debentures

	September 30, 2015			December 31, 2014
Convertible notes payable	$	663,222		$	604,472
Unamortized debt discount		(138,264	)		(412,543	)
Carrying amount	$	524,958		$	191,929
Less: current portion		(471,546	)		(168,962	)
Long-term convertible notes, net	$	53,412		$	22,968

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Schedule of Fair Value Measurements

			Fair Value Measurements at  September 30, 2015 using:
	September 30, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Derivative Liabilities	$	873,348		—		—	$	873,348

Schedule of Summary of Changes in Fair Value

		Derivative Liability
Balance, December 31, 2014	$	1,018,782
Additions		668,537
Change in fair value of derivative liabilities		(813,971	)
Balance, September 30, 2015	$	873,348

XML

Acquisition of Xtreme Technologies, Inc. (Tables)

9 Months Ended

Sep. 30, 2015

Acquisition Of Xtreme Technologies Inc. Tables

Schedule of Estimated Fair Value of Assets and Liabilities Acquired

ASSETS:
Current assets	$	144,112
Property & equipment		91,431
Intangible assets		1,400,000
Goodwill		658,187
Total	$	2,293,730
LIABILITIES:
Current liabilities	$	243,730
Net purchase price	$	2,050,000

Schedule of Unaudited Pro Forma Consolidated Results of Operations

	Nine months ended September 30,
	2015			2014
	(Unaudited)			(Unaudited)
Revenue	$	804,676		$	989,844
Net loss from continuing operations	$	(1,792,303	)	$	(1,658,811	)
Net loss per share from continuing operations	$	(0.01	)	$	(0.02	)
Weighted average number of common stock shares – Basic and diluted		181,985,547			74,045,606

XML

Nature of Operations and Continuance of Business (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2015	Jan. 13, 2015
Date of Incorporation	Apr. 19, 2010
Current Fiscal Year End Date	--12-31
Series C Preferred Stock Designated, Stated Value	$ 1
Alkame Water Inc.
Date of Acquisition	Jun. 25, 2013
Shares Issued, related party	116,666,667
Shares Issued, former shareholders of Alkame Water	33,333,333
Shares Issued, Reverse Merger	150,000,000
Acquisition of Alkame Water	100.00%
Acquisition of the Company by Alkame Water	71.00%
Xtreme SPA
Date of Agreement	Apr. 21, 2014
Purchase Price	$ 2,050,000
Cash Payment	50,000
Additional Cash Payment	525,000
Initial Deposit	50,000
Balance	$ 1,425,000
Common Stock, shares	1,009,000
Common Stock, Price Per Share	$ 0.10
Xtreme SPA Amdt
Date of Agreement	Dec. 09, 2015
Balance	$ 1,425,000
Series C Preferred Stock Designated, Stated Value	$ 1
Preferred Stock, Series C, to be issued	1,425,000
Xtreme Acquisition
Series C Preferred Stock Designated, Stated Value	$ 1
Preferred Stock, Series C, to be issued	1,425,000
Xtreme
Purchase Price		$ 2,050,000

XML

Going Concern (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ (11,156,906)		$ (11,156,906)		$ (8,471,350)
Revenues	$ 199,320	$ 6,665	$ 800,571	$ 105,676

XML

Basis of Presentation (Details Narrative)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Current Fiscal year end	--12-31

XML

Summary of Significant Accounting Policies - Schedule of Anti-Dilutive Series A Convertible Preferred Stock (Details) - shares	Sep. 30, 2015	Sep. 30, 2014
Preferred Stock, Series A, Issued and Outstanding	12,000,000
Preferred Stock, Series B, Issued and Outstanding	65,398,334
Common Share Equivalent
Preferred Stock, Series A, Issued and Outstanding	600,000,000	600,000,000
Preferred Stock, Series B, Issued and Outstanding	65,398,334	65,398,334
Preferred Stock, Series C, Issued and Outstanding	356,250,000
Convertible notes payable	356,576,614	5,862,185
Warrants	1,587,302
EROP conversion of debt	136,543,519

XML

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Summary Of Significant Accounting Policies Details Narrative
Bad debt reserve	$ 148,000	$ 23,000

XML

Notes Payable (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2014	May. 01, 2013	Apr. 08, 2013
Repayments of note payable			$ 44,691	$ 7,000
Note payable related party	$ 38,199		38,199			$ 43,490
Accrued interest	237,852		$ 237,852			146,046
Financing Costs				1,001,280
Amortization of deferred finance costs	11,441	$ 18,549	$ 74,810	$ 34,799
Deferred finance costs	11,898		11,898			63,375
Total current liabilities	5,440,167		5,440,167			2,643,808
Total long-term liabilities	79,611		$ 79,611			154,458
Promissory Note 2
Debt Instrument, Date			Mar. 11, 2014
Debt Instrument, Amount	100,000		$ 100,000
Accrued interest	183,625		183,625
Total current liabilities	850,000		$ 850,000
Promissory Note
Debt Instrument, Date			Mar. 29, 2013
Debt Instrument, Amount	$ 500,000		$ 500,000
Promissory Note, receivable							$ 300,000	$ 200,000
Debt Instrument, Interest Rate	10.00%		10.00%
Debt Instrument, Maturity Date			Mar. 30, 2015
Promissory Note 1
Note payable related party					$ 63,000
Promissory Note, receivable					$ 10,000
Debt Instrument, Amended Date					Aug. 01, 2013
Debt Instrument, Interest Rate					5.00%
Consultant #1
Expenses paid on behalf of the Company			$ 75,000
Consultant #2
Expenses paid on behalf of the Company			$ 10,000
Prom Note Amdt #1
Debt Instrument, Date			Sep. 27, 2013
Debt Instrument, Amount	$ 250,000		$ 250,000
Debt Instrument, Interest Rate	10.00%		10.00%
Debt Instrument, Maturity Date			Sep. 27, 2015
EROP
Debt Instrument, Date			Jan. 01, 2015
Debt Instrument, Amount	$ 525,000		$ 525,000
Debt Instrument, Balance	$ 207,000		$ 207,000
Promissory Note 2
Accrued interest						$ 119,875

XML

Convertible debt - Convertible Notes and Debentures (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Debt Disclosure [Abstract]
Proceeds from convertible notes	$ 663,222
Unamortized debt discount	(138,264)	$ (412,543)
Carrying amount	524,958	191,929
Less: current portion	(471,546)	(168,962)
Long-term convertible notes, net	$ 53,412	$ 22,968

XML

Convertible debt (Details Narrative) - USD ($)

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Oct. 29, 2015

Mar. 05, 2015

Feb. 25, 2015

Feb. 19, 2015

Feb. 10, 2015

Feb. 09, 2015

Jan. 29, 2015

Jan. 22, 2015

Dec. 16, 2014

Nov. 12, 2014

Oct. 27, 2014

Oct. 24, 2014

Sep. 11, 2014

Sep. 05, 2014

Sep. 04, 2014

Aug. 11, 2014

Aug. 06, 2014

Proceeds from convertible notes

$ 663,222

Interest expense

$ 57,660

$ 1,032,993

133,082

$ 1,073,546

Amortization of Debt Discount

(161,324)

$ (46,845)

(628,111)

(46,845)

Gain on change in fair value of derivative liability

$ 499,266

$ 374,363

Accredited Investor #3

Date of Agreement

Aug. 11, 2014

Proceeds from convertible notes

$ 45,000

Convertible Debt, term

5 months

Convertible Debt, description

The debenture is convertible at 50% of the lowest traded price in the 20 days prior to the conversion.

Derivative Fair Value

0

$ 0

$ 131,493

Derivative Liability Adjustment

86,493

86,493

Amortization of Debt Discount

7,500

$ 37,500

Gain on change in fair value of derivative liability

$ 58,401

Accredited Investor #4

Date of Agreement

Sep. 04, 2014

Proceeds from convertible notes

$ 42,500

Convertible Debt, term

9 months

Convertible Debt, description

The debenture is convertible at 58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.

Derivative Fair Value

0

$ 0

$ 52,597

Derivative Liability Adjustment

10,097

10,097

Amortization of Debt Discount

23,611

18,889

Gain on change in fair value of derivative liability

$ 59,207

Accredited Investor #5

Date of Agreement

Sep. 05, 2014

Proceeds from convertible notes

$ 52,500

Convertible Debt, term

1 year

Convertible Debt, description

The debenture is convertible at 53% of the lowest trading price in the 20 trading days prior to the conversion.

Derivative Fair Value

73,499

$ 73,499

$ 578,343

Derivative Liability Adjustment

525,843

525,843

Amortization of Debt Discount

35,000

17,500

Gain on change in fair value of derivative liability

$ 16,678

Accredited Investor #6

Date of Agreement

Sep. 11, 2014

Proceeds from convertible notes

$ 56,250

Convertible Debt, term

9 months

Convertible Debt, description

The debenture is convertible at 55% of the average of the two lowest trading price in the 25 trading days prior to conversion.

Derivative Fair Value

0

$ 0

$ 300,489

Derivative Liability Adjustment

244,239

244,239

Amortization of Debt Discount

31,250

25,000

Gain on change in fair value of derivative liability

$ 84,645

Accredited Investor #7

Date of Agreement

Oct. 24, 2014

Proceeds from convertible notes

$ 55,000

Convertible Debt, term

1 year

Convertible Debt, description

The debenture is convertible at 60% of the lowest closing price in the 20 trading days prior to conversion.

Original Issue Discount

$ 5,000

Derivative Fair Value

50,792

50,792

$ 162,550

Derivative Liability Adjustment

107,550

107,550

Amortization of Debt Discount

41,250

13,750

Gain on change in fair value of derivative liability

$ 34,423

Accredited Investor #8

Date of Agreement

Oct. 27, 2014

Proceeds from convertible notes

$ 33,000

Convertible Debt, term

2 years

Convertible Debt, description

The debenture is convertible at lesser of (a) $0.15 or (b) 60% of the lowest trading price in the 25 trading days prior to conversion.

Original Issue Discount

$ 3,000

Derivative Fair Value

53,565

53,565

$ 100,870

Derivative Liability Adjustment

67,870

67,870

Amortization of Debt Discount

12,375

4,125

Gain on change in fair value of derivative liability

$ 4,182

Accredited Investor #9

Date of Agreement

Oct. 29, 2014

Proceeds from convertible notes

$ 55,000

Convertible Debt, term

1 year

Convertible Debt, description

The debenture is convertible at lesser of (a) $0.10 or (b) 60% of the lowest trading price in the 25 trading days prior to conversion.

Original Issue Discount

$ 5,000

Derivative Fair Value

55,221

55,221

$ 142,870

Derivative Liability Adjustment

87,870

87,870

Amortization of Debt Discount

41,250

13,750

Gain on change in fair value of derivative liability

$ 33,270

Accredited Investor #2

Date of Agreement

Aug. 06, 2014

Proceeds from convertible notes

$ 68,000

Convertible Debt, term

9 months

Convertible Debt, description

The debenture is convertible at 58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.

Derivative Fair Value

0

$ 0

$ 94,657

Derivative Liability Adjustment

32,145

32,145

Amortization of Debt Discount

30,222

37,778

Gain on change in fair value of derivative liability

$ 90,253

Accredited Investor #11

Date of Agreement

Dec. 16, 2014

Proceeds from convertible notes

$ 39,772

Convertible Debt, term

2 years

Convertible Debt, description

The debenture is convertible at 60% of the lowest trading price in the 25 trading days prior to conversion.

Derivative Fair Value

64,323

$ 64,323

$ 85,288

Derivative Liability Adjustment

45,566

45,566

Amortization of Debt Discount

14,895

1,655

Gain on change in fair value of derivative liability

$ 5,665

Accredited Investor #12

Date of Agreement

Jan. 22, 2015

Proceeds from convertible notes

$ 75,000

Convertible Debt, term

1 year

Convertible Debt, description

The debenture is convertible at 55% of the lowest trading price in the 20 trading days prior to conversion.

Derivative Fair Value

97,161

$ 97,161

$ 210,982

Derivative Liability Adjustment

135,982

135,982

Amortization of Debt Discount

56,250

Gain on change in fair value of derivative liability

$ 113,821

Accredited Investor #13

Date of Agreement

Jan. 29, 2015

Proceeds from convertible notes

$ 28,000

Convertible Debt, term

9 months

Convertible Debt, description

The debenture is convertible at 55% of the lowest trading price in the 20 trading days prior to conversion.

Derivative Fair Value

23,754

$ 23,754

$ 46,247

Derivative Liability Adjustment

18,247

18,247

Amortization of Debt Discount

27,999

Gain on change in fair value of derivative liability

$ 22,493

Accredited Investor #14

Date of Agreement

Feb. 09, 2015

Proceeds from convertible notes

$ 108,000

Convertible Debt, term

1 year

Convertible Debt, description

The debenture is convertible at 60% of the lowest trading price in the 20 trading days prior to conversion.

Derivative Fair Value

141,415

$ 141,415

$ 192,372

Derivative Liability Adjustment

73,521

73,521

$ 73,521

Amortization of Debt Discount

72,000

Gain on change in fair value of derivative liability

$ 40,106

Accredited Investor #15

Date of Agreement

Feb. 10, 2015

Proceeds from convertible notes

$ 22,000

Convertible Debt, term

2 years

Convertible Debt, description

The debenture is convertible at 60% of the lowest trading price in the 25 trading days prior to conversion.

Derivative Fair Value

37,011

$ 37,011

$ 41,170

Derivative Liability Adjustment

19,710

19,710

Amortization of Debt Discount

10,083

Gain on change in fair value of derivative liability

$ 4,159

Accredited Investor #16

Date of Agreement

Feb. 19, 2015

Proceeds from convertible notes

$ 35,000

Convertible Debt, term

2 years

Convertible Debt, description

The debenture is convertible at 50% of the lowest trading price in the 20 trading days prior to conversion.

Derivative Fair Value

57,479

$ 57,479

$ 53,829

Derivative Liability Adjustment

18,829

18,829

Amortization of Debt Discount

23,333

Gain on change in fair value of derivative liability

$ (3,650)

Accredited Investor #17

Date of Agreement

Feb. 25, 2015

Proceeds from convertible notes

$ 33,333

Convertible Debt, term

2 years

Convertible Debt, description

The debenture is convertible at the lower of (a) $0.10 per share; or (b) 60% of the lowest trading price in the 25 trading days prior to conversion.

Derivative Fair Value

64,625

$ 64,625

$ 61,358

Derivative Liability Adjustment

20,932

20,932

Amortization of Debt Discount

11,112

Gain on change in fair value of derivative liability

$ 5,059

Accredited Investor #18

Date of Agreement

Mar. 05, 2015

Proceeds from convertible notes

$ 52,500

Convertible Debt, term

8 months

Convertible Debt, description

The debenture is convertible at 53% of the lowest trading price in the 20 trading days prior to the conversion.

Derivative Fair Value

97,718

$ 97,718

$ 73,432

Derivative Liability Adjustment

20,932

20,932

Amortization of Debt Discount

30,625

Gain on change in fair value of derivative liability

$ 8,807

Accredited Investor #10

Date of Agreement

Nov. 12, 2014

Proceeds from convertible notes

$ 75,000

Convertible Debt, term

1 year

Convertible Debt, description

The debenture is convertible at 50% of the lowest trading price in the 20 trading days prior to conversion.

Derivative Fair Value

101,204

$ 101,204

$ 324,627

Derivative Liability Adjustment

$ 249,627

249,627

Amortization of Debt Discount

56,250

4,795

Gain on change in fair value of derivative liability

$ 94,135

Warrants

1,587,302

1,587,302

Warrants, exercise price

$ 0.24

$ 0.24

Accredited Investor

Date of Agreement

Aug. 06, 2014

Proceeds from convertible notes

$ 82,500

Convertible Debt, term

1 year

Convertible Debt, description

The debenture is convertible at the lesser of $0.10 per share, or 60% of the lowest trade price in the 25 trading days prior to conversion.

Interest expense

7,500

Original Issue Discount

$ 7,500

Derivative Fair Value

$ 0

0

$ 190,451

Derivative Liability Adjustment

$ 107,951

107,951

Amortization of Debt Discount

65,313

$ 17,187

Gain on change in fair value of derivative liability

$ 142,317

XML

Fair Value of Financial Instruments - Schedule of Fair Value Measurements (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current liabilities
Derivative instrument liability	$ 873,348	$ 1,018,782
Fair Value, Inputs, Level 3
Current liabilities
Derivative instrument liability	$ 873,348

XML

Fair Value of Financial Instruments - Schedule of Summary of Changes in Fair Value (Details) - USD ($)	6 Months Ended	9 Months Ended
	Jun. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Derivative liability on convertible notes at inception		$ 668,537
Change in fair value of derivative liability		(813,971)
Derivative instrument liability		$ 873,348		$ 1,018,782

XML

Related Party Transactions (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Related Party Transactions [Abstract]
Proceeds from related parties	$ 22,967
Loans from officer	26,456		$ 3,489
Accrued liabilites, consulting	$ 210,000		$ 120,000

XML

Stockholders Equity (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Jan. 24, 2014
Common Stock, Par Value	$ .001		$ 0.001
Common Stock, Shares Authorized	900,000,000		900,000,000
Common Stock, Issued and outstanding	181,985,547		74,045,606
Preferred Stock, Par Value	$ .001
Preferred Stock, Shares Authorized	20,000,000		20,000,000
Preferred Stock, Series A, Designated	12,000,000		12,000,000
Preferred Stock, Series B, Designated	70,000,000		70,000,000
Preferred Stock, Series C, Designated	10,000,000
Series C Preferred Stock Designated, Stated Value	$ 1
Authorized Issuance Preferred Stock, Shares				100,000,000
Authorized Issuance Preferred Stock, Par Value				$ 0.001
Shares Authorized, Shares				1,000,000,000
Shares Authorized, Par Value				$ 0.001
Authorized Issuance Common Stock, Shares				90,000,000
Series B Preferred Stock Designated, Shares				70,000,000
Series B Preferred Stock Designated, Par Value				$ 0.001
Sereis C Preferred Stock Designated, Shares				10,000,000
Sereis C Preferred Stock Desiganted, Par Value				$ 0.001
Stockholder Exchange
Common Shares Exchanged for Series B Preferred Stock	65,210,834
Series B Preferred Stock Issued for Exchange for Common Shares	65,210,834
Date of Issuance	Jan. 28, 2014
Group Settlement
Common Stock, Par Value	$ 0.01926
Date of Issuance	Jan. 12, 2015
Common Stock, issued	3,600,000
Accounts and notes payable, settlement	$ 69,336
Group Settlement #2
Common Stock, Par Value	$ 0.01706
Date of Issuance	Feb. 01, 2015
Common Stock, issued	6,500,000
Accounts and notes payable, settlement	$ 110,910
Debt Conversion
Common Stock, Par Value	$ 0.01291
Date of Issuance	Feb. 01, 2015
Common Stock, issued, conversions	13,365,052
Common Stock, issued, conversions, value	$ 166,970
Debt Instrument, Accrued Interest	$ 5,557
Group Settlement #3
Common Stock, Par Value	$ 0.00426	$ 0.0024
Date of Issuance	Mar. 01, 2015	Apr. 01, 2015
Common Stock, issued	16,100,000	6,000,000
Accounts and notes payable, settlement	$ 68,508	$ 14,400
Debt Conversion #2
Common Stock, Par Value	$ 0.0108
Date of Issuance	Mar. 01, 2015
Common Stock, issued, conversions	24,373,736
Common Stock, issued, conversions, value	$ 138,113
Debt Instrument, Accrued Interest	$ 4,013
Group Settlement #10
Common Stock, Par Value	$ 0.0024
Date of Issuance	Dec. 01, 2015
Common Stock, issued	7,500,000
Accounts and notes payable, settlement	$ 18,000
Group Settlement #5
Common Stock, Par Value		$ 0.00698
Date of Issuance		Jun. 01, 2015
Common Stock, issued		10,118,865
Accounts and notes payable, settlement		$ 70,613
Group Settlement #6
Common Stock, Par Value		$ 0.00336
Date of Issuance		Aug. 01, 2015
Common Stock, issued		8,000,000
Accounts and notes payable, settlement		$ 26,800
Group Settlement #8
Common Stock, Par Value		$ 0.00198
Date of Issuance		Sep. 01, 2015
Common Stock, issued		5,482,288
Accounts and notes payable, settlement		$ 10,855
Group Settlement #9
Common Stock, Par Value		$ 0.00192
Date of Issuance		Nov. 01, 2015
Common Stock, issued		9,000,000
Accounts and notes payable, settlement		$ 17,280
Group Settlement #4
Common Stock, Par Value		$ 0.00402
Date of Issuance		May 01, 2015
Common Stock, issued		7,400,000
Accounts and notes payable, settlement		$ 29,748
Group Settlement #7
Common Stock, Par Value		$ 0.003
Common Stock, issued		7,000,000
Accounts and notes payable, settlement		$ 21,000

XML

Acquisition of Xtreme Technologies, Inc. - Schedule of Estimated Fair Value of Assets and Liabilities Acquired (Details) - USD ($)	Sep. 30, 2015	Jan. 13, 2015	Dec. 31, 2014
ASSETS
Total current assets	$ 288,172		$ 585,483
Manufacturing equipment, net	129,161		11,149
Intangible assets, net	1,080,051		4,509
Total assets	1,548,409		750,911
LIABILITIES AND STOCKHOLDERS DEFICIT
Total current liabilities	5,440,167		$ 2,643,808
Xtreme SPA 1
LIABILITIES AND STOCKHOLDERS DEFICIT
Purchase Price	2,050,000
Xtreme Acquisition 1
ASSETS
Intangible assets, net	$ 1,400,000
Xtreme
ASSETS
Total current assets		$ 144,112
Manufacturing equipment, net		91,431
Intangible assets, net		1,400,000
Goodwill		658,187
Total assets		2,293,730
LIABILITIES AND STOCKHOLDERS DEFICIT
Total current liabilities		243,730
Purchase Price		$ 2,050,000

XML

Acquisition of Xtreme Technologies, Inc. - Schedule of Unaudited Pro Forma Consolidated Results of Operations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenues	$ 199,320	$ 6,665	$ 800,571	$ 105,676
Loss from operations	$ (1,423,026)	$ (381,057)	$ (2,349,446)	$ (929,726)
Net Loss per share - basic and diluted	$ (0.01)	$ (0.02)	$ (0.02)	$ (0.02)
Weighted average number of shares outstanding- basic and diluted	169,231,116	70,558,287	137,263,440	76,557,282
Xtreme SPA 1
Revenues			$ 804,676	$ 989,844
Loss from operations			$ (1,792,303)	$ (1,658,811)
Net Loss per share - basic and diluted			$ (0.01)	$ (0.02)
Weighted average number of shares outstanding- basic and diluted			181,985,547	74,045,606

XML

Acquisition of Xtreme Technologies, Inc. (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Jan. 13, 2015	Dec. 31, 2014
Intangible assets, net	$ 1,080,051			$ 4,509
Series C Preferred Stock Designated, Stated Value	$ 1
Trade Names
Intangible Asset Useful Life	3 years
Xtreme Acquisition
Amortization Expense	$ 102,571	$ 0
Series C Preferred Stock Designated, Stated Value	$ 1
Preferred Stock, Series C, to be issued	1,425,000
Patents
Intangible Asset Useful Life	7 years
Xtreme SPA 1
Series C Preferred Stock Designated, Stated Value	$ 1
Preferred Stock, Series C, to be issued	1,425,000
Xtreme Acquisition 1
Intangible assets, net	$ 1,400,000
Amortization Expense Remainder Of Fiscal Year	24,107
Amortization Expense, Year Two	192,857
Amortization Expense, Year Three	192,857
Amortization Expense, Year Four	167,857
Amortization Expense, Year Five through Nine	142,857
Amortization Expense, After Year Five	71,429
Intangible assets,	1,080,051
Series C Preferred Stock Designated, Stated Value	$ 1
Preferred Stock, Series C, to be issued	1,425,000
Xtreme
Intangible assets, net			$ 1,400,000

XML

Subsequent events (Details Narrative) - USD ($)

9 Months Ended

12 Months Ended

Sep. 30, 2015

Dec. 31, 2015

Dec. 31, 2014

Common Stock, Par Value

$ .001

$ 0.001

Preferred Stock, Series D, Par Value

$ 0.001

Preferred Stock, Series D, Designated

4,000,000

Preferred Stock, Series D, description

The series is convertible into common stock of the Company at a conversion of ten (10) shares of common stock for every Series D Preferred Stock. In addition, holders of the series can vote in matters submitted for vote by the shareholders at the rate of twenty-five thousand (25,000) votes for each share held.

Consultant #1

Payment to Consultant

$ 120,000

Preferred Stock, Series D, To be Issued

1,000,000

CEO

Officer Compensation

$ 120,000

Preferred Stock, Series D, To be Issued

1,000,000

Group Settlement #10

Date of Issuance

Dec. 01, 2015

Common Stock, issued

7,500,000

Accounts and notes payable, settlement

$ 18,000

Common Stock, Par Value

$ 0.0024

Group Settlement #9

Date of Issuance

Nov. 01, 2015

Common Stock, issued

9,000,000

Accounts and notes payable, settlement

$ 17,280

Common Stock, Par Value

$ 0.00192